Continuous positive airway pressure

CPAP

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Operations: NOMESCO codes — ^WX722 1 out of 7 registries used, show all original rules.	9719
4. Check minimum number of events None	9719
5. Include endpoints None	9719
6. Filter based on genotype QC (FinnGen only)	9719

Control definitions (FinnGen only)

Control exclude: ILD_COMORB

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	CPAP
CONTROL_EXCLUDE	ILD_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM	^WX722
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Continuous positive airway pressure based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	62273	23857	38134
Only index persons	45606	16596	29010
Unadjusted period prevalence (%)
Whole population	0.92	0.68	1.07
Only index persons	0.93	0.61	1.11
Median age at first event (years)
Whole population	57.66	59.07	56.68
Only index persons	62.08	64.84	60.50

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9719	3717	6002
Unadjusted period prevalence (%)	2.12	1.27	2.65
Median age at first event (years)	63.23	62.12	63.92

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8322: Matched controls
74098

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C09AA05

ATC

ramipril; oral

4.9

323.0

2197

5073

C10AA01

ATC

simvastatin; oral

3.4

323.0

3664

13846

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

664.2

323.0

358

205

Kela drug reimbursment

Chronic hypertension

3.8

323.0

2422

7267

TPH07

NOMESCO Finland

Cathetrisation of artery

8.6

323.0

1536

1907

C03CA01

ATC

furosemide; systemic

9.2

323.0

3153

4619

I50.1

ICD-10 Finland

Left ventricular failure

30.6

323.0

515

159

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

323.0

605

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

7.5

323.0

1716

2464

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

4.2

323.0

2586

7124

R5140

NOMESCO Finland

Monitoring the use of the aid

15.6

323.0

2990

2564

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

12.2

323.0

2323

2286

A10BH01

ATC

sitagliptin; oral

2064.1

323.0

965

M04AA01

ATC

allopurinol; systemic

5.1

323.0

1306

2623

G47.3

ICD-10 Finland

Sleep apnoea

35.1

323.0

6320

6106

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

323.0

446

R06.0

ICD-10 Finland

Dyspnoea

5.2

323.0

2597

5912

AA1AD

NOMESCO Finland

CT of head and brain

4.2

323.0

2032

5313

C10AA05

ATC

atorvastatin; oral

3.4

323.0

3194

11555

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

19.8

323.0

581

279

F32.9

ICD-10 Finland

Depressive episode, unspecified

16.2

323.0

952

587

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1092.2

323.0

353

J96.1

ICD-10 Finland

Chronic respiratory failure

1618.6

323.0

336

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

8.7

323.0

1914

2458

C08CA01

ATC

amlodipine; oral

3.3

323.0

3190

11821

TPH04

NOMESCO Finland

Cathetrisation of vein

4.8

323.0

2223

5195

T90

ICPC

Diabetes non-insulin dependent

32.1

323.0

2410

927

XG466

NOMESCO Finland

Sleep oxymetry

37.4

323.0

1275

356

SPAT1262

SPAT

Handing over of treatment supplies

10.7

323.0

1992

2117

GD1AA

NOMESCO Finland

Thorax X-ray examination

5.6

323.0

4808

14502

B01AC04

ATC

clopidogrel; oral

12.5

323.0

1256

1037

WX892

NOMESCO Finland

Monitored bed care

13.9

323.0

1157

849

R4110

NOMESCO Finland

Physiotherapy

3.3

323.0

2868

10079

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

81.5

323.0

627

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.2

323.0

2391

6546

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

97.6

323.0

648

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

54.1

323.0

411

B01AA03

ATC

warfarin; systemic

11.1

323.0

1709

1685

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

27.4

323.0

617

216

TFP20

NOMESCO Finland

Cardiodefibrillation

253.2

323.0

631

E11

ICD-10 Finland

Type 2 diabetes mellitus

33.8

323.0

1633

531

R03BB04

ATC

tiotropium bromide; inhalant

5.7

323.0

1132

1982

XF404

NOMESCO Finland

Ambulatory ECG

11.2

323.0

827

722

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

19.9

323.0

2149

1273

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

11.6

323.0

2245

2283

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

57.2

323.0

479

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

5.7

323.0

1062

1853

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

323.0

698

I20.99

ICD-10 Finland

Angina pectoris, unspecified

77.8

323.0

423

A02BC02

ATC

pantoprazole; systemic

3.0

323.0

5560

29613

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2616.5

323.0

568

R03AC02

ATC

salbutamol; inhalant

2.6

323.0

4451

22648

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

7.9

323.0

2230

3274

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

153.1

323.0

892

I10

ICD-10 Finland

Essential (primary) hypertension

4.4

323.0

5487

22559

C07AB07

ATC

bisoprolol; oral

7.0

323.0

4380

10102

A10BA02

ATC

metformin; oral

130.4

323.0

2929

307

I25.1

ICD-10 Finland

Atherosclerotic heart disease

130.7

323.0

1880

165

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

94.1

323.0

880

C07AB02

ATC

metoprolol; systemic

4.1

323.0

1494

3781

I50.9

ICD-10 Finland

Heart failure, unspecified

26.6

323.0

1700

708

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

113.2

323.0

491

A10BK01

ATC

dapagliflozin; oral

690.7

323.0

442

TKC20

NOMESCO Finland

Catheterisation of bladder

7.9

323.0

1084

1372

AN1

Coronary angiography

21.1

323.0

953

450

C01DA14

ATC

isosorbide mononitrate; oral

22.4

323.0

1273

591

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

71.4

323.0

455

A10BD07

ATC

metformin and sitagliptin; systemic

3027.4

323.0

336

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

529.2

323.0

1091

A10BB12

ATC

glimepiride; oral

472.2

323.0

640

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

26.9

323.0

496

174

Z2446

NOMESCO Finland

Social worker

7.2

323.0

881

1196

I25.2

ICD-10 Finland

Old myocardial infarction

1932.1

323.0

632

R07.4

ICD-10 Finland

Chest pain, unspecified

3.5

323.0

2174

6767

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

323.0

360

E66.8

ICD-10 Finland

Other obesity

112.1

323.0

839

WX725

NOMESCO Finland

Noninvasive ventilation

+∞

323.0

414

Z3226

NOMESCO Finland

Physiotherapist

3.9

323.0

2133

5992

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

45.8

323.0

481

E66.9

ICD-10 Finland

Obesity, unspecified

65.1

323.0

464

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1364.8

323.0

566

I50.0

ICD-10 Finland

Congestive heart failure

40.7

323.0

915

224

WX730

NOMESCO Finland

Conventional respirator

47.7

323.0

447

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

162.5

323.0

641

I20.09

ICD-10 Finland

Unstable angina

216.4

323.0

416

215

Kela drug reimbursment

Diabetes, non-insulin-treated

16384.0

323.0

2552

207

Kela drug reimbursment

Chronic arrhythmias

294.7

323.0

1141

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

49.8

323.0

1389

296

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

323.0

908

A10AE04

ATC

insulin glargine; parenteral

857.4

323.0

942

A10AE05

ATC

insulin detemir; parenteral

1864.5

323.0

417

C01AA05

ATC

digoxin; systemic

26.5

323.0

624

226

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1039.6

323.0

443

K78

ICPC

Atrial fibrillation/flutter

27.3

323.0

554

193

C03DA01

ATC

spironolactone; oral

9.8

323.0

1276

1344

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

15.4

323.0

783

496

J45.9

ICD-10 Finland

Asthma, unspecified

3.6

323.0

1696

4853

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

11.4

323.0

794

678

E66.01

ICD-10 Finland

Obesity due to excess calories

61.6

323.0

1307

223

E66.00

ICD-10 Finland

Metabolic syndrome

34.3

323.0

880

254

A10BK03

ATC

empagliflozin; oral

639.1

323.0

663

A10BJ06

ATC

semaglutide; parenteral

+∞

323.0

406

WX882

NOMESCO Finland

High dependency care

14.2

323.0

705

479

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

6.5

323.0

1464

2360

XF400

NOMESCO Finland

ECG with 12 standard connections

8.2

323.0

2312

3331

Z2221

NOMESCO Finland

Medical doctor

3.5

323.0

2919

9890

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

323.0

362

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

323.0

382

N02AX02

ATC

tramadol; systemic, rectal

2.7

323.0

3775

17536

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

5.5

323.0

1178

2139

N06AB04

ATC

citalopram; systemic

4.1

323.0

1817

4746

H02AB06

ATC

prednisolone; systemic

2.5

323.0

4032

20189

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

5.3

323.0

1872

3849

B01AF02

ATC

apixaban; oral

22.7

323.0

767

330

103

Kela drug reimbursment

Diabetes, insulin-treated

1974.2

323.0

2802

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

45.2

323.0

462

WX722

NOMESCO Finland

PEEP

+∞

323.0

8323

A10BH05

ATC

linagliptin; oral

1849.8

323.0

414

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

137.0

323.0

424

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

9.1

323.0

1002

1100

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

4.5

323.0

2304

5852

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

7.4

323.0

2124

3272

Z3231

NOMESCO Finland

Registered nurse

3.8

323.0

3021

9609

XF402

NOMESCO Finland

ECG with work load test

7.6

323.0

1160

1538

ZXD05

NOMESCO Finland

Urgent procedure

3.2

323.0

2661

9447

I48

ICD-10 Finland

Atrial fibrillation and flutter

99.3

323.0

1949

228

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

88.1

323.0

2534

366

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

6.3

323.0

1036

1629

ZX120

NOMESCO Finland

Intravenous

4.7

320.6

1224

2606

T82

ICPC

Obesity

18.0

319.6

526

276

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1532.6

317.4

321

N06AX16

ATC

venlafaxine; oral

5.2

316.2

1096

2099

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

126.1

315.5

353

WX872

NOMESCO Finland

Intensive care

14.0

315.3

574

390

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

10.2

314.5

667

625

A10BJ02

ATC

liraglutide; parenteral

281.6

313.4

332

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

982.7

313.4

319

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

10.7

306.8

636

570

Angiography of the heart and coronary arteries

28.2

303.4

434

144

SPAT1263

SPAT

Sampling

2.5

302.9

3328

15436

N03AX16

ATC

pregabalin; oral

3.0

302.8

2131

7542

160

Kela drug reimbursment

exenatide

+∞

300.8

300

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

7.2

297.9

785

1053

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

101.7

297.4

340

L28

ICPC

Limited function/disability (L)

3.8

293.1

1433

3832

N02BE01

ATC

paracetamol; systemic, rectal

2.7

287.6

6931

47747

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

4.4

285.9

1181

2702

N05AH04

ATC

quetiapine; oral

4.7

285.7

1093

2315

E66

ICD-10 Finland

Obesity

12.5

283.8

543

411

R02

ICPC

Shortness of breath/dyspnoea

4.6

281.7

1088

2325

Z01.8

ICD-10 Finland

Other specified special examinations

3.1

280.8

1894

6465

R01AD09

ATC

mometasone; nasal

2.3

280.0

3905

20252

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.4

276.3

1563

4685

I25

ICD-10 Finland

Chronic ischaemic heart disease

47.3

276.1

352

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.3

275.3

1643

5128

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

27.4

269.1

388

132

R06.5

ICD-10 Finland

Mouth breathing

4.2

269.0

1155

2732

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.8

268.7

1307

3458

C01BD01

ATC

amiodarone; systemic

510.1

268.6

278

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

10.7

266.9

551

487

I20.90

ICD-10 Finland

Angina pectoris, unspecified

506.3

266.6

276

XG410

NOMESCO Finland

Flow-volume spirometry

8.6

266.4

623

690

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

832.8

266.1

272

N06AX11

ATC

mirtazapine; oral

2.7

266.1

2335

9381

J01MA12

ATC

levofloxacin; systemic

3.1

266.1

1786

6048

I20.00

ICD-10 Finland

Unstable angina

2360.2

264.1

266

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.4

263.9

3394

16750

RK320

NOMESCO Finland

38.0

262.2

349

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

6.6

261.8

736

1076

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

20.7

261.2

409

184

Z3229

NOMESCO Finland

Other healthcare associate professional

4.5

260.2

1037

2278

P06

ICPC

Sleep disturbance

4.5

259.3

1020

2211

J01DB01

ATC

cefalexin; oral

2.5

255.8

6629

45408

I50

ICD-10 Finland

Heart failure

28.5

253.8

362

118

A10BB01

ATC

glibenclamide; oral

189.5

247.2

268

WX408

NOMESCO Finland

General anesthesy, balanced

2.5

245.5

2414

10265

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

3.6

245.4

1287

3605

N05BA04

ATC

oxazepam; oral

2.9

244.7

1788

6365

R53

ICD-10 Finland

Malaise and fatigue

3.2

243.9

1521

4858

201

Kela drug reimbursment

Chronic cardiac insufficiency

16.3

242.3

413

236

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

14.8

241.2

428

271

SPAT1254

SPAT

Administration of medicine

3.8

239.5

1167

3071

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.9

236.4

722

1172

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

7.0

234.6

626

847

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

552.9

234.3

242

A10BG03

ATC

pioglitazone; oral

434.1

228.7

238

A46

ICD-10 Finland

Erysipelas

3.4

228.6

1263

3670

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

37.9

228.2

304

N06AB10

ATC

escitalopram; oral

3.2

227.8

1377

4280

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

14.3

224.5

404

264

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.0

223.6

1491

4960

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.7

221.7

839

1735

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

+∞

221.2

221

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

109.2

220.2

250

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.3

220.0

1296

3944

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.4

219.9

1205

3470

H02AB07

ATC

prednisone; oral

3.1

219.0

1436

4714

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

7.2

218.8

573

753

N06AX12

ATC

bupropion; oral

9.5

218.6

479

471

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.4

218.5

2354

10389

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

5.0

217.6

765

1461

C09AA02

ATC

enalapril; systemic

2.9

215.2

1560

5470

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

999.6

214.8

219

I49.5

ICD-10 Finland

Sick sinus syndrome

232.9

213.8

229

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.0

213.6

966

2368

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

6.1

212.8

631

983

N05CF01

ATC

zopiclone; oral

2.4

212.7

2408

10869

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.1

210.9

4139

23927

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

+∞

209.1

209

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

8.9

208.6

475

499

N06AX21

ATC

duloxetine; oral

4.4

208.4

829

1799

177

Kela drug reimbursment

Insulin glargine 300 U / ml

+∞

206.1

206

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

10.7

203.3

418

364

A02BC05

ATC

esomeprazole; systemic

2.1

200.9

3153

16475

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

934.0

200.8

205

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.7

199.2

621

1028

SPAT1216

SPAT

Assessment of functional ability

3.1

199.2

1261

4019

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

98.4

197.0

226

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

3.1

196.5

1249

3989

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

20.7

196.2

307

137

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

4.5

195.3

761

1613

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

+∞

195.0

195

J01FF01

ATC

clindamycin; systemic

2.3

194.2

2236

10094

B01AC24

ATC

ticagrelor; oral

1704.9

193.8

196

M10.9

ICD-10 Finland

Gout, unspecified

5.6

193.5

616

1045

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

161.2

193.2

212

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

12.8

193.1

364

264

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

234.0

191.5

205

T89

ICPC

Diabetes insulin dependent

110.1

191.4

217

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

597.0

191.0

197

AN3

Balloon angioplasty and metallic stent

+∞

191.0

191

XCK10

NOMESCO Finland

Photography of fundus of eye

4.3

190.9

777

1718

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.6

190.6

1625

6241

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.3

189.8

1072

3137

R60.0

ICD-10 Finland

Localized oedema

3.6

189.1

956

2564

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.7

188.8

926

2422

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.4

187.9

2025

8822

N06AB03

ATC

fluoxetine; oral

3.8

187.4

897

2297

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

4.0

186.5

841

2044

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

296.7

186.3

197

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

185.3

3656

20785

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

7.9

184.1

450

530

A10AA02

ATC

1612.3

183.7

186

WX002

NOMESCO Finland

Sedation and analgesia

2.5

183.1

1761

7214

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

+∞

182.0

182

I20.01

ICD-10 Finland

Unstable angina

1593.8

181.7

184

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

1593.8

181.7

184

SPAT1104

SPAT

Monitoring of emergency patient

4.8

180.8

656

1288

R04

ICPC

Breathing problem other

7.0

180.3

478

636

AA1

Conventional CABG

+∞

179.9

180

C03AA03

ATC

hydrochlorothiazide; oral

4.0

179.4

805

1945

J96.0

ICD-10 Finland

Acute respiratory failure

35.0

178.0

241

I49.3

ICD-10 Finland

Ventricular premature depolarization

9.5

178.0

389

379

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

54.6

177.9

221

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.5

177.7

947

2642

SPAT1310

SPAT

Counselling related to known health issue

2.2

177.4

2310

10970

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.3

176.3

727

1624

T36

ICD-10 Finland

Poisoning by systemic antibiotics

17.4

174.9

290

153

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

1686.6

174.7

177

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

6.1

174.1

513

788

C10AA07

ATC

rosuvastatin; oral

2.4

173.2

1744

7292

5CM18

NOMESCO Finland

241.0

173.1

185

I48.2

ICD-10 Finland

Chronic atrial fibrillation

+∞

172.9

173

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

6.9

172.4

462

624

A10BX07

ATC

[U] liraglutide; parenteral

+∞

171.9

172

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1630.6

169.7

172

J01CA04

ATC

amoxicillin; systemic

2.0

169.2

6291

44740

AN4

Balloon angioplasty and drug eluding stent

+∞

166.9

167

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

4.5

165.8

639

1333

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

4.6

165.3

624

1274

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

164.7

2860

15253

UJF32

NOMESCO Finland

Coloscopy

2.3

164.7

1957

8856

WX110

NOMESCO Finland

Local anesthesy

1.9

164.4

5274

35254

C10AX09

ATC

ezetimibe; oral

4.1

163.6

696

1597

F34.1

ICD-10 Finland

Dysthymia

16.1

163.5

279

159

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

163.2

2435

12191

M79.6

ICD-10 Finland

Pain in limb

2.0

161.4

2626

13616

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

10.2

161.4

340

309

B01AB05

ATC

enoxaparin; parenteral

2.1

161.4

2259

10991

C08CA13

ATC

lercanidipine; oral

3.1

160.5

1012

3183

N06AB06

ATC

sertraline; oral

4.1

160.1

687

1588

C02AC05

ATC

moxonidine; oral

7.0

159.1

420

554

162

Kela drug reimbursment

liraglutide

+∞

158.9

159

C09CA01

ATC

losartan; oral

2.3

158.9

1864

8363

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

51.8

158.9

199

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

1509.1

158.7

161

A28

ICPC

Limited function/disability NOS

3.0

157.0

1032

3335

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

8.7

156.4

361

386

I48.1

ICD-10 Finland

Persistent atrial fibrillation

297.1

156.1

165

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

4.3

155.7

635

1398

Single vessel balloon catheter extension

+∞

152.9

153

R03BA05

ATC

fluticasone; inhalant

2.4

152.0

1494

6118

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

+∞

151.9

152

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.9

151.7

3254

18643

N05AH03

ATC

olanzapine; systemic

11.6

151.7

299

238

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

26.4

151.6

220

J01DA01

ATC

[U] cefalexin; systemic

1.8

151.2

4769

31225

SPAT1229

SPAT

Assessment of need for aid

4.1

151.2

655

1525

A04

ICPC

Weakness/tiredness general

3.2

150.0

886

2654

A12BA01

ATC

potassium chloride; oral

7.6

149.9

374

453

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

33.4

149.9

205

N05CD07

ATC

temazepam; oral

3.2

149.8

885

2651

A02BC01

ATC

omeprazole; systemic

2.2

149.5

1952

9158

A10AE06

ATC

insulin degludec; parenteral

+∞

148.8

149

1CX08

NOMESCO Finland

182.5

148.1

161

N17.9

ICD-10 Finland

Acute renal failure, unspecified

7.9

148.0

361

422

A10AA01

ATC

+∞

147.8

148

M54.5

ICD-10 Finland

Low back pain

2.0

147.0

2372

12157

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

6.6

147.0

408

577

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

682.9

146.9

151

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

682.9

146.9

151

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

8.5

146.6

342

372

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.6

146.6

558

1146

ZXE20

NOMESCO Finland

More than three and less than five hours

2.7

146.5

1136

4066

I47.2

ICD-10 Finland

Ventricular tachycardia

204.7

146.4

158

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

+∞

145.8

146

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

6.4

145.0

408

588

N05AA02

ATC

levomepromazine; systemic

11.4

144.1

286

231

P76

ICPC

Depressive disorder

7.4

144.0

365

453

J01AA02

ATC

doxycycline; systemic

1.9

143.6

6187

44659

L17

ICPC

Foot/toe symptom/complaint

2.2

142.3

1801

8305

R01AD08

ATC

fluticasone; nasal

2.0

141.9

2291

11713

UJF30

NOMESCO Finland

Ileoscopy through colon

3.1

141.7

869

2669

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

140.8

141

SPAT1240

SPAT

Therapeutic discussion

4.1

140.8

603

1387

I42.0

ICD-10 Finland

Dilated cardiomyopathy

13.6

140.7

257

173

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

39.8

139.9

184

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

12.8

139.5

262

188

XG405

NOMESCO Finland

Education on PEF monitoring

11.1

139.3

280

232

P03

ICPC

Feeling depressed

4.9

138.7

488

921

R03AK07

ATC

formoterol and budesonide; inhalant

2.3

138.3

1578

6924

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

+∞

137.8

138

B01AF01

ATC

rivaroxaban; oral

3.1

137.4

854

2644

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.8

137.3

1035

3634

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

136.9

3019

17289

A10BX04

ATC

[U] exenatide; parenteral

+∞

136.8

137

TK800

NOMESCO Finland

Hemodialysis

10.9

136.7

277

233

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

11.5

136.6

270

216

TFP34

NOMESCO Finland

Electrophysiological investigation

108.1

136.5

155

N03AX09

ATC

lamotrigine; oral

8.1

135.2

324

368

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.6

135.2

1144

4296

I47.1

ICD-10 Finland

Supraventricular tachycardia

23.6

134.9

202

OAB50

SPAT

28.3

133.5

190

N05BA01

ATC

diazepam; systemic, rectal

2.9

133.4

897

2925

SPAT1054

SPAT

Examination of peripheral nervous system

42.4

133.3

173

SPAT1097

SPAT

Recording of ECG

2.7

132.5

1007

3548

C01BC04

ATC

flecainide; systemic

50.2

131.9

166

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.7

131.8

485

960

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

5.7

131.6

410

672

D64.9

ICD-10 Finland

Anaemia, unspecified

3.4

131.6

696

1911

G47.9

ICD-10 Finland

Sleep disorder, unspecified

8.1

131.2

315

359

E66.0

ICD-10 Finland

Obesity due to excess calories

212.6

131.0

141

A10BH02

ATC

vildagliptin; oral

408.2

130.3

136

L03

ICPC

Low back symptom/complaint

2.1

129.0

1690

7869

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.1

129.0

555

1279

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

128.5

1650

7614

C08CA02

ATC

felodipine; oral

3.4

128.5

688

1906

H02AB04

ATC

methylprednisolone; systemic

2.4

128.4

1236

4965

F29

ICD-10 Finland

Unspecified nonorganic psychosis

61.4

128.1

156

Coronary artery bypass surgery

+∞

127.8

128

AN2

Balloon angioplasty, including several vessels

+∞

127.8

128

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.6

127.8

638

1672

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

4.1

127.7

540

1225

R42

ICD-10 Finland

Dizziness and giddiness

2.3

126.6

1407

6071

N05AX12

ATC

aripiprazole; systemic

29.4

126.3

178

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

46.8

125.6

160

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

392.8

125.4

131

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

4.1

125.1

535

1226

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

124.9

2093

10759

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

1146.6

124.7

127

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1146.6

124.7

127

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

6.6

124.0

340

472

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

30.2

123.6

173

I35.0

ICD-10 Finland

Aortic (valve) stenosis

5.2

122.9

414

743

C09CA06

ATC

candesartan; oral

2.1

122.3

1639

7681

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

121.8

122

AP1

Catheterization of the left side of the heart

43.1

121.4

157

A02BA02

ATC

ranitidine; systemic

2.2

121.4

1399

6129

SPAT1305

SPAT

Counselling and guidance related to physical exercise

3.2

121.0

692

2012

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

5.6

120.4

375

614

N05BA12

ATC

alprazolam; oral

3.1

120.1

747

2303

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

120.1

2917

17055

XA420

NOMESCO Finland

Extensive sleep examination

12.1

119.8

230

173

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.5

119.8

383

647

A06AD11

ATC

lactulose; oral

2.6

119.5

968

3526

C08DB01

ATC

diltiazem; oral

5.9

119.5

357

555

GD1LA

NOMESCO Finland

26.5

118.8

172

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.8

118.8

431

839

S97

ICPC

Chronic ulcer skin

5.0

118.6

412

765

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.3

118.5

663

1896

XG474

NOMESCO Finland

Exhalation nntrogen oxide

6.2

118.2

342

510

N06AA09

ATC

amitriptyline; systemic

3.1

117.8

722

2204

XF600

NOMESCO Finland

Bloodpressure measurement

3.9

117.7

527

1257

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.8

116.6

540

1326

N19

ICD-10 Finland

Unspecified kidney failure

7.2

116.2

300

382

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.0

116.0

1958

10044

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.3

115.7

1281

5493

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

7.8

115.7

283

332

J01FA06

ATC

roxithromycin; oral

1.8

115.0

2983

17743

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

114.8

2366

13043

SPAT1211

SPAT

Application of soft bandage

3.0

114.4

748

2383

ZXE00

NOMESCO Finland

One hour or less

1.8

114.3

2850

16733

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.7

113.5

413

806

F32

ICD-10 Finland

Depressive episode

5.7

112.6

345

553

RK110

NOMESCO Finland

17.4

112.6

186

N07BB01

ATC

disulfiram; oral

6.5

112.0

312

442

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

18.8

112.0

180

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

3.8

111.8

510

1235

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.7

111.6

845

2952

R4120

NOMESCO Finland

Occupational therapy

3.6

111.5

543

1390

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

5.4

111.4

358

608

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

4.3

111.4

445

954

K77

ICPC

Heart failure

24.8

111.3

164

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.7

111.2

866

3076

ZXA00

NOMESCO Finland

Right side

1.9

110.9

2124

11383

R03BA02

ATC

budesonide; inhalant

2.2

110.8

1306

5754

XF640

NOMESCO Finland

9.0

110.6

248

252

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

20.0

110.5

174

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

180.5

110.4

120

C09DA01

ATC

losartan and diuretics; oral

2.7

110.0

849

3000

A10BD03

ATC

metformin and rosiglitazone; systemic

+∞

109.8

110

P01AB01

ATC

metronidazole; oral, rectal

1.8

109.6

2791

16443

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.7

109.6

398

775

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.6

109.0

906

3342

C09BA02

ATC

enalapril and diuretics; systemic

3.2

108.9

633

1857

F41.1

ICD-10 Finland

Generalized anxiety disorder

10.6

107.9

221

190

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

49.2

107.8

136

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.9

107.7

736

2410

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.1

107.6

658

2000

SPAT1325

SPAT

Vaccination

1.8

106.9

2376

13368

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

13.2

106.7

197

136

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.2

106.1

1258

5549

280

Kela drug reimbursment

Clopidogrel

972.6

105.8

108

WX890

NOMESCO Finland

Intesive care monitoring

39.3

105.6

139

N06AX26

ATC

vortioxetine; oral

5.4

105.4

340

580

WX320

NOMESCO Finland

Spinalanesthesy

1.9

105.2

1802

9245

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

105.0

2588

15039

C07AG02

ATC

carvedilol; oral

4.1

104.9

440

987

N02AA05

ATC

oxycodone; systemic

2.4

104.6

1039

4209

J45

ICD-10 Finland

Asthma

2.8

104.3

755

2562

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

4.1

104.2

442

1002

DHB50

NOMESCO Finland

Turbinoplasty

5.2

103.8

345

609

A10BG02

ATC

rosiglitazone; oral

954.3

103.8

106

A10BJ01

ATC

exenatide; parenteral

+∞

103.8

104

R51.80

ICD-10 Finland

Headache

2.5

103.8

905

3422

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.4

103.6

562

1566

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

5.9

103.5

308

476

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.6

103.1

829

2995

ZXA05

NOMESCO Finland

Left side

1.9

102.7

1978

10575

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

8.6

102.2

235

249

N03AX12

ATC

gabapentin; oral

2.4

102.0

1015

4112

H3601, E113

ICD-10 Finland

+∞

101.8

102

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

43.8

101.7

131

C10AA04

ATC

fluvastatin; oral

3.2

101.3

581

1684

I20.91

ICD-10 Finland

Angina pectoris, unspecified

471.5

101.1

105

R05FB02

ATC

cough suppressants and expectorants

1.7

101.0

2828

17042

A08

ICPC

Swelling

4.8

100.8

360

688

J20

ICD-10 Finland

Acute bronchitis

2.8

100.7

722

2434

J01MA02

ATC

ciprofloxacin; systemic

1.7

100.5

2812

16937

A02BC03

ATC

lansoprazole; oral

1.9

100.3

1954

10471

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

100.2

1676

8498

A10BJ05

ATC

dulaglutide; parenteral

+∞

99.8

100

N03AG01

ATC

valproic acid; systemic, rectal

4.7

99.0

365

721

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.2

99.0

576

1688

A10AB06

ATC

insulin glulisine; parenteral

+∞

98.8

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

29.2

98.7

139

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.5

98.6

866

3283

F61.0

ICD-10 Finland

Mixed personality disorders

42.5

98.1

127

RD210

NOMESCO Finland

8.9

97.9

221

227

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

97.9

4012

26845

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.3

97.8

392

842

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

97.8

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

17.4

97.5

161

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

15.0

97.3

170

103

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.2

97.3

1122

4872

L15

ICPC

Knee symptom/complaint

2.0

97.1

1534

7600

K02.1

ICD-10 Finland

Caries of dentine

1.6

97.1

4020

26949

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.7

97.0

457

1136

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.8

96.9

451

1109

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

9.0

96.7

216

218

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

69.2

96.2

115

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

13.6

96.1

175

117

M01AE02

ATC

naproxen; oral, rectal

1.6

95.9

4265

29099

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

+∞

95.8

NOMESCO Finland

Other rehabilitation services

+∞

95.8

R05

ICD-10 Finland

Cough

2.0

95.5

1403

6751

K90

ICPC

Stroke/cerebrovascular accident

17.3

95.1

157

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

+∞

94.8

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

24.6

94.3

139

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

107.1

94.3

107

J46

ICD-10 Finland

Status asthmaticus

6.8

93.4

249

332

UKC02

NOMESCO Finland

Cystoscopy

2.1

93.4

1163

5218

SPAT1281

SPAT

Other administrative function

3.0

93.3

588

1818

RK510

NOMESCO Finland

225.2

93.3

100

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

76.3

93.3

110

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

92.8

1910

10386

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.1

92.6

564

1704

R4190

NOMESCO Finland

Nutritional therapy

4.5

92.0

353

726

J01MA14

ATC

moxifloxacin; systemic

2.7

92.0

697

2426

SPAT1051

SPAT

Guidance regarding sleep disorders

8.3

91.8

216

238

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

91.8

C07AA07

ATC

sotalol; systemic

8.1

91.8

219

247

WX290

NOMESCO Finland

Other blockade of nerve

1.7

91.7

2992

18700

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.3

91.5

937

3836

M10

ICD-10 Finland

Gout

4.2

91.3

372

811

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

23.6

91.2

136

RK520

NOMESCO Finland

21.4

91.2

140

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.8

91.0

277

440

M10.0

ICD-10 Finland

Idiopathic gout

5.8

91.0

275

433

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.6

90.9

740

2684

Z25.1

ICD-10 Finland

Need for immunization against influenza

3.0

90.6

564

1730

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.2

90.6

525

1532

R03DC03

ATC

montelukast; oral

2.1

90.4

1147

5183

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.9

90.3

405

964

N05AX08

ATC

risperidone; systemic

4.1

90.2

375

833

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

282.6

89.7

P01

ICPC

Feeling anxious/nervous/tense

3.6

89.6

438

1122

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.4

89.5

347

721

R03DA04

ATC

theophylline; systemic, rectal

3.7

89.4

430

1086

Z2445

NOMESCO Finland

Psychologist

5.8

89.2

270

426

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

88.8

B01AC07

ATC

dipyridamole; systemic

6.5

88.2

243

339

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.6

88.0

429

1096

J45.1

ICD-10 Finland

Nonallergic asthma

3.1

87.7

529

1588

JN3AD

NOMESCO Finland

Abdominal CT examination

2.9

87.6

571

1805

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.6

87.5

724

2647

B01AE07

ATC

dabigatran etexilate; oral

6.8

87.4

234

314

H25.8

ICD-10 Finland

Other senile cataract

2.5

86.4

769

2926

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

9.2

86.1

190

188

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

790.3

85.9

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

274.9

85.8

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

+∞

85.8

WX704

NOMESCO Finland

Intubation

3.4

85.4

447

1208

J37.0

ICD-10 Finland

Chronic laryngitis

4.9

85.3

298

556

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

22.4

85.2

129

A99

ICPC

Disease/condition unspecnature/site

2.8

85.2

606

2026

R95

ICPC

Chron obstructive pulmonary disease

6.7

85.0

230

313

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.9

85.0

1587

8309

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

21.1

85.0

131

C08DA01

ATC

verapamil; systemic

5.7

85.0

260

416

H04AA01

ATC

glucagon; nasal, parenteral

88.2

84.6

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

9.3

84.6

185

180

RK250

NOMESCO Finland

21.3

84.6

130

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

393.8

84.3

M25.5

ICD-10 Finland

Pain in joint

1.8

84.3

1969

11097

GD1AD

NOMESCO Finland

Thorax CT examination

4.0

84.2

361

825

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

5.4

84.2

270

457

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.2

84.2

919

3873

ZY010

NOMESCO Finland

Hospital outpatient

5.0

84.0

289

530

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

772.1

83.9

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

3.4

83.9

436

1172

N05AB03

ATC

perphenazine; systemic, rectal

10.0

83.8

176

159

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

+∞

83.8

E0000UV

ATC

1.6

83.5

2719

16870

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

7.9

83.5

201

230

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.9

83.5

564

1824

SPAT1234

SPAT

Support of social functional capacity

4.3

83.2

331

705

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

9.2

83.2

183

180

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

6.4

83.1

232

330

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

265.4

82.8

N05BE01

ATC

buspirone; oral

7.6

82.8

205

245

R50.9

ICD-10 Finland

Fever, unspecified

2.2

82.6

951

4103

M48.0

ICD-10 Finland

Spinal stenosis

2.3

82.6

822

3311

N05BA06

ATC

lorazepam; systemic, sublingual

4.2

82.3

340

751

N06AA12

ATC

doxepin; systemic

4.1

82.1

349

791

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

82.1

993

4380

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.3

81.7

450

1264

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

22.6

81.6

123

E10

ICD-10 Finland

Type 1 diabetes mellitus

197.8

81.5

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

81.5

2632

16268

A10BX01

ATC

guar gum; systemic

6.5

81.4

226

319

4019X

ICD-9 Finland

Essential hypertension, Unspecified

8.7

81.3

185

193

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

29.4

81.2

114

R05

ICPC

Cough

1.9

81.2

1471

7609

N06AB05

ATC

paroxetine; oral

3.7

81.1

384

957

J01CE02

ATC

phenoxymethylpenicillin; oral

1.6

81.1

5027

36549

F10.20

ICD-10 Finland

Alcohol dependence currently independent

39.8

80.9

106

C09CA03

ATC

valsartan; oral

2.6

80.9

631

2228

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

+∞

80.8

R06AE07

ATC

cetirizine; oral

1.6

80.7

2968

18975

R2110

NOMESCO Finland

Giving the first information

3.0

80.6

514

1601

A11CC03

ATC

alfacalcidol; systemic

6.7

80.5

218

297

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

80.4

2279

13572

C10AA03

ATC

pravastatin; oral

3.3

80.4

433

1196

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.0

80.2

498

1523

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.0

80.1

499

1527

R06.2

ICD-10 Finland

Wheezing

3.7

80.0

374

922

N03AE01

ATC

clonazepam; systemic

3.5

80.0

398

1033

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

79.9

2769

17417

3AC01

NOMESCO Finland

12.6

79.9

150

108

WW200

SPAT

0.3

79.8

131

4380

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

79.8

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.9

79.2

1463

7612

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

78.8

NF1AA

NOMESCO Finland

Hip X-ray examination

2.5

78.6

660

2426

S18

ICPC

Laceration/cut

1.6

78.5

2891

18453

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.7

78.4

1962

11250

R00.1

ICD-10 Finland

Bradycardia, unspecified

7.3

78.2

198

245

R04.0

ICD-10 Finland

Epistaxis

3.1

78.1

466

1384

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.8

77.6

555

1859

H03AA01

ATC

levothyroxine sodium; systemic

1.8

77.5

1494

7878

A41.9

ICD-10 Finland

Sepsis, unspecified

4.8

77.3

277

531

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

9.8

77.1

164

152

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.5

77.0

242

400

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

77.0

1312

6624

RK123

NOMESCO Finland

708.5

76.9

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

708.5

76.9

M79.1

ICD-10 Finland

Myalgia

2.2

76.1

852

3622

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

13.8

76.0

137

Z01.2

ICD-10 Finland

Dental examination

1.6

75.8

2890

18562

F32.1

ICD-10 Finland

Moderate depressive episode

5.4

75.8

241

404

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

149.1

75.4

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

75.4

2512

15576

N05AF03

ATC

chlorprothixene; systemic

20.1

75.4

118

R32

ICD-10 Finland

Unspecified urinary incontinence

5.3

75.4

243

414

R99

ICPC

Respiratory disease other

7.2

75.2

193

244

WW200

NOMESCO Finland

Immunization

4.6

74.7

280

562

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

7.2

74.7

192

243

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.7

74.7

273

534

R07.3

ICD-10 Finland

Other chest pain

2.7

74.6

566

1963

WZA90

NOMESCO Finland

Other doctors statement

1.8

74.5

1538

8284

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

22.1

74.5

113

N04BC05

ATC

pramipexole; oral

2.7

74.3

561

1941

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

681.2

73.9

RS221

NOMESCO Finland

8.4

73.8

171

184

H3600, E113

ICD-10 Finland

+∞

73.8

D82

ICPC

Teeth/gum disease

1.6

73.8

2421

14934

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.4

73.7

710

2804

TK810

NOMESCO Finland

Hemofiltration

26.5

73.6

106

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

15.0

73.6

128

M79.7

ICD-10 Finland

Fibromyalgia

5.5

73.5

231

382

K07

ICPC

Swollen ankles/oedema

4.2

73.2

295

636

E87.5

ICD-10 Finland

Hyperkalaemia

12.6

73.2

137

WW804

NOMESCO Finland

Transfer from treating institution to higher-Level care, accompanied by doctor

48.7

73.0

EB1MA

NOMESCO Finland

Cephalometry with X-ray

5.1

72.8

246

442

RK290

NOMESCO Finland

30.3

72.6

101

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.5

72.6

623

2316

H36.00

ICD-10 Finland

Diabetic background retinopathy

339.2

72.4

N18.0

ICD-10 Finland

End-stage renal disease

13.6

72.3

131

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.7

72.3

1774

10076

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.8

72.2

326

780

WW500

NOMESCO Finland

Blood transfusion

3.5

71.9

357

924

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

71.8

1315

6797

F10.09

ICD-10 Finland

Alcohol intoxication UNS

56.5

71.6

I44.2

ICD-10 Finland

Atrioventricular block, complete

7.7

71.2

175

207

F41.00

ICD-10 Finland

Moderate panic disorder

50.0

71.0

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

7.9

70.8

171

197

H3603, E103

ICD-10 Finland

+∞

70.8

R03BA08

ATC

ciclesonide; inhalant

2.5

70.7

615

2304

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

17.0

70.6

117

R03AC13

ATC

formoterol; inhalant

3.3

70.4

387

1084

IGY99

NOMESCO Finland

Other psychiatric treatment contact

12.5

70.4

132

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.0

70.3

300

682

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

16.0

70.2

119

R55

ICD-10 Finland

Syncope and collapse

2.5

70.1

616

2317

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

224.6

70.0

M01AB01

ATC

indometacin; systemic, rectal

2.5

70.0

616

2321

K03.66

ICD-10 Finland

Tooth plaque

2.7

69.9

516

1760

RS220

NOMESCO Finland

8.9

69.8

156

158

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

69.6

1379

7310

C09AA04

ATC

perindopril; oral

3.4

69.5

368

1002

NG2AA

NOMESCO Finland

Patella X-ray examination

4.2

69.3

283

618

K99

ICPC

Cardiovascular disease other

7.1

69.2

178

226

R60.9

ICD-10 Finland

Oedema, unspecified

3.6

69.2

338

864

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

2.0

69.1

1033

4952

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

221.4

69.1

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

68.9

495

1659

IGY02

NOMESCO Finland

Psychiatric monitoring contact

13.0

68.9

127

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

68.8

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

+∞

68.8

SPAT1252

SPAT

Overall medication plan or its review

3.2

68.8

397

1152

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.0

68.7

944

4373

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

68.7

4987

36855

L16

ICPC

Ankle symptom/complaint

2.4

68.5

658

2593

XG460

NOMESCO Finland

Short time oxymetry

6.8

68.3

182

243

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

5.9

68.2

203

314

Z02.7

ICD-10 Finland

Issue of medical certificate

3.1

67.8

408

1218

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.9

67.8

439

1378

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

67.5

1478

8083

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

98.8

67.5

J81

ICD-10 Finland

Pulmonary oedema

34.1

67.3

R11

ICD-10 Finland

Nausea and vomiting

2.9

67.2

453

1458

M01AB05

ATC

diclofenac; systemic, rectal

1.5

67.0

5121

38159

A10BX02

ATC

repaglinide; oral

617.8

67.0

E000001

ATC

1.8

67.0

1357

7236

J01MA01

ATC

ofloxacin; systemic

2.3

67.0

691

2819

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

14.1

66.8

119

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.6

66.7

522

1841

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.3

66.7

697

2861

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

7.5

66.6

166

201

C08CA05

ATC

nifedipine; systemic

3.1

66.6

399

1189

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

44.9

66.6

N06AG02

ATC

moclobemide; oral

4.0

66.5

288

664

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

5.6

66.4

205

332

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

7.6

66.4

163

193

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

608.7

66.0

SPAT1301

SPAT

No procedures

1.7

65.9

1864

10980

XQ800

NOMESCO Finland

Prick test

2.5

65.8

554

2035

H3600, E103

ICD-10 Finland

+∞

65.8

ZY000

NOMESCO Finland

Hospital inpatient

24.2

65.8

C09DA06

ATC

candesartan and diuretics; oral

2.6

65.8

535

1928

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.1

65.8

386

1133

FXG00

NOMESCO Finland

Insertion and use of IABP

307.3

65.5

K29

ICPC

Cardiovascular sympt/complt other

4.0

65.3

278

631

R96

ICPC

Asthma

2.5

65.3

577

2176

R03BB01

ATC

ipratropium bromide; inhalant

3.7

65.1

306

757

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

8.9

65.1

146

149

M03BX02

ATC

tizanidine; oral

1.5

65.0

4572

33351

H3603, E113

ICD-10 Finland

+∞

64.8

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

64.7

4430

32119

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

13.3

64.6

118

Z49.1

ICD-10 Finland

Extracorporeal dialysis

10.6

64.3

131

112

ZXE90

NOMESCO Finland

More than 22 hours

17.5

64.2

105

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.4

64.1

247

510

N06AX03

ATC

mianserin; oral

4.1

64.1

270

607

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

590.6

64.0

SPAT1260

SPAT

Consultation of another employee

1.9

64.0

1068

5321

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

+∞

63.8

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

4.7

63.8

231

448

UJD02

NOMESCO Finland

Gastroscopy

3.6

63.5

309

787

K05.31

ICD-10 Finland

Periodontitis pronounced

2.2

63.5

687

2866

N05AN01

ATC

lithium; oral

12.5

63.4

119

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.7

63.4

1761

10306

S76

ICPC

Skin infection other

3.1

63.2

368

1074

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

23.5

63.2

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.5

63.2

546

2032

SPAT1255

SPAT

Intravenous administration of medicine

2.8

63.1

431

1400

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.0

63.1

894

4185

RK120

NOMESCO Finland

22.5

63.1

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

63.0

3614

25175

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

62.8

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

+∞

62.8

NHQ40

NOMESCO Finland

Amputation of toe

10.5

62.7

128

110

F60.9

ICD-10 Finland

Personality disorder, unspecified

44.9

62.7

A07AA02

ATC

nystatin; oral

2.8

62.5

428

1392

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

62.3

3253

22187

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.9

62.2

402

1258

F41.09

ICD-10 Finland

UNS Panic Syndrome

10.6

62.1

126

107

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

62.0

2844

18841

C02EA02

ATC

3.9

62.0

269

621

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.2

61.9

725

3133

J34.2

ICD-10 Finland

Deviated nasal septum

2.6

61.9

492

1749

R35

ICD-10 Finland

Polyuria

2.7

61.9

454

1540

358

Kela drug reimbursment

liraglutide

+∞

61.8

A01

ICPC

Pain general/multiple sites

2.7

61.6

466

1610

R01AD12

ATC

fluticasone furoate; nasal

1.6

61.5

1989

12108

J96.9

ICD-10 Finland

Respiratory failure, unspecified

30.5

61.4

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

15.5

61.3

105

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

11.5

61.1

119

A10BX09

ATC

[U] dapagliflozin; oral

563.5

61.0

FN1AD

NOMESCO Finland

CT of coronary arteries

8.4

60.9

141

152

F10.25

ICD-10 Finland

Alcohol dependence continuous use

36.3

60.9

A10BB07

ATC

glipizide; oral

122.0

60.8

N18.8

ICD-10 Finland

Other chronic renal failure

5.6

60.8

188

305

A10BD20

ATC

metformin and empagliflozin; systemic

+∞

60.8

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

12.9

60.7

112

XKD00

NOMESCO Finland

Uroflowmetry

1.8

60.6

1167

6101

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.2

60.6

699

2997

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

284.6

60.6

C07AB03

ATC

atenolol; systemic

3.3

60.4

326

900

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

4.9

60.3

208

383

F99

ICD-10 Finland

Mental disorder, not otherwise specified

11.6

60.3

117

G04CA02

ATC

tamsulosin; oral

1.7

60.1

1537

8770

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

554.4

60.1

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

10.4

59.9

123

107

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.8

59.9

405

1307

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

70.9

59.8

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

+∞

59.8

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

59.8

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

25.2

59.8

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

280.0

59.6

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

59.4

1570

9037

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

7.0

59.4

154

198

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.7

59.3

280

696

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

58.7

59.1

N30.0

ICD-10 Finland

Acute cystitis

2.1

59.1

756

3390

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

545.4

59.1

RD112

NOMESCO Finland

63.8

59.0

R03AC12

ATC

salmeterol; inhalant

3.3

58.9

325

913

A02BC04

ATC

rabeprazole; oral

2.4

58.8

563

2209

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

+∞

58.8

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.8

58.7

402

1307

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.3

58.7

190

326

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.4

58.4

536

2059

-48

ICPC

Clarification/discussion RFE/demand

4.7

58.2

211

410

R31

ICD-10 Finland

Unspecified haematuria

2.2

57.9

649

2748

N05CF02

ATC

zolpidem; oral

1.8

57.9

1101

5725

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.8

57.7

390

1257

A03FA02

ATC

cisapride; oral, rectal

2.5

57.6

502

1876

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

2.5

57.5

492

1820

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

9.2

57.5

126

124

F31.8

ICD-10 Finland

Other bipolar affective disorders

19.7

57.4

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

10.1

57.3

119

106

R78

ICPC

Acute bronchitis/bronchiolitis

4.8

57.3

204

389

Z72.0

ICD-10 Finland

Tobacco use

6.1

57.0

163

240

M70.6

ICD-10 Finland

Trochanteric bursitis

2.1

57.0

729

3268

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.2

57.0

322

919

JN4BD

NOMESCO Finland

Extensive body CT

2.0

56.9

816

3830

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

97.1

56.9

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

18.6

56.9

B03BA03

ATC

hydroxocobalamin; parenteral

2.9

56.8

363

1129

EBA00

NOMESCO Finland

Extraction of tooth

1.6

56.5

2040

12717

SPAT1053

SPAT

Memory test

2.0

56.5

853

4084

A08AB01

ATC

orlistat; oral

34.1

56.4

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

56.2

2880

19436

SPAT1312

SPAT

General health counselling

1.6

56.1

1968

12178

F20.9

ICD-10 Finland

Schizophrenia, unspecified

138.9

56.1

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

9.8

56.0

118

108

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

95.6

56.0

R03AC03

ATC

terbutaline; inhalant

1.9

55.7

892

4361

D07AC01

ATC

betamethasone; topical

1.5

55.6

2290

14717

K29.3

ICD-10 Finland

Chronic superficial gastritis

4.3

55.6

221

471

X58

ICD-10 Finland

Exposure to other specified factors

1.9

55.3

965

4864

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

179.2

55.3

ZXD00

NOMESCO Finland

Emergency procedure

4.5

55.3

210

428

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

18.2

55.2

Z97.4

ICD-10 Finland

Presence of external hearing-aid

2.9

55.2

367

1170

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

111.1

55.0

W19

ICD-10 Finland

Unspecified fall

2.2

55.0

603

2524

P15

ICPC

Chronic alcohol abuse

6.8

54.9

146

195

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

+∞

54.8

5315

FHL

Bypass surgery using a mammary artery

+∞

54.8

L14

ICPC

Leg/thigh symptom/complaint

2.4

54.7

493

1875

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.0

54.7

735

3360

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.5

54.7

469

1736

R4140

NOMESCO Finland

Psychotherapy

38.0

54.7

M01AX17

ATC

nimesulide; oral

1.6

54.7

1741

10507

L08

ICPC

Shoulder symptom/complaint

1.7

54.6

1250

6881

R03AK08

ATC

formoterol and beclometasone; inhalant

3.3

54.6

289

787

C09DA03

ATC

valsartan and diuretics; oral

3.0

54.5

344

1061

XA800

NOMESCO Finland

Neuropsychological investigation

3.7

54.4

251

612

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.1

53.9

691

3096

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

5.1

53.9

180

320

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

53.8

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

+∞

53.8

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.6

53.7

197

388

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

2.1

53.6

683

3054

K84

ICPC

Heart disease other

8.9

53.6

119

120

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

39.2

53.5

N06AX05

ATC

trazodone; oral

6.3

53.5

149

212

FXZ00

NOMESCO Finland

Off-pump cardiac operation

58.2

53.3

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.5

53.3

448

1640

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

53.2

1007

5217

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

53.2

1939

12084

L13

ICPC

Hip symptom/complaint

1.8

53.1

1009

5234

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

79.4

53.1

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

53.1

997

5153

R74

ICPC

Upper respiratory infection acute

1.6

53.0

1642

9827

R5110

SPAT

4.1

52.9

218

481

C07AA05

ATC

propranolol; systemic

1.8

52.8

1042

5471

SPAT1231

SPAT

Assessment of adjustments needed in living environment

5.9

52.7

155

237

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

24.7

52.7

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

52.7

1629

9744

B03XA02

ATC

darbepoetin alfa; parenteral

5.8

52.6

158

248

C09DX04

ATC

valsartan and sacubitril; oral

53.0

52.5

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

14.2

52.5

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

4.8

52.5

185

349

SPAT1360

SPAT

Extensive global examination

2.4

52.5

489

1891

F32.8

ICD-10 Finland

Other depressive episodes

19.1

52.5

WNF00

NOMESCO Finland

Infection source and contact determination

18.4

52.4

ZXA10

NOMESCO Finland

Bilateral

1.7

52.3

1222

6758

K92.1

ICD-10 Finland

Melaena

3.2

52.0

294

839

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

+∞

51.8

V03AE01

ATC

polystyrene sulfonate; oral

10.4

51.8

106

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

20.5

51.8

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

51.7

1689

10236

R03AK11

ATC

formoterol and fluticasone; inhalant

4.0

51.6

219

496

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

51.6

588

2503

P20

ICPC

Memory disturbance

2.1

51.5

658

2944

J31.0

ICD-10 Finland

Chronic rhinitis

2.2

51.4

545

2245

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

4.7

51.4

186

361

K28

ICPC

Limited function/disability (K)

6.5

51.3

140

194

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.2

51.3

289

823

L90

ICPC

Osteoarthrosis of knee

2.4

51.2

461

1752

F33

ICD-10 Finland

Recurrent depressive disorder

10.3

51.1

105

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

13.6

51.0

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

21.2

51.0

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

6.9

51.0

133

173

RK323

NOMESCO Finland

24.0

50.9

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.4

50.9

473

1826

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

+∞

50.8

H3601, E103

ICD-10 Finland

+∞

50.8

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.8

50.7

345

1117

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.6

50.5

395

1389

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

3.3

50.3

270

743

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

22.0

50.3

K30

ICD-10 Finland

Functional dyspepsia

2.1

50.3

612

2680

H36.01

ICD-10 Finland

Diabetic maculopathy

102.1

50.2

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

50.0

3941

28739

C09CA07

ATC

telmisartan; oral

2.3

49.9

511

2069

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

237.9

49.7

C07AB08

ATC

celiprolol; oral

4.8

49.7

176

334

A11

ICPC

Chest pain NOS

2.5

49.6

406

1464

K76

ICPC

Ischaemic heart dis without angina

18.0

49.5

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

49.5

1754

10827

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

123.1

49.3

M02AA07

ATC

piroxicam; topical

1.5

49.3

2575

17321

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

49.3

1599

9658

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.0

49.3

207

465

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6603

39729

2.36

321.94

4.4

2.5

u/l

64.3

43.9

42.77

6123

36945

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1738

5685

2.99

320.42

4.2

5.3

u/l

249.8

246.2

0.40

1617

5442

(3013650) Neutrophils [#/volume] in Blood by Automated count

5770

32999

2.26

314.07

10.7

9.0

e9/l

4.6

3.8

101.13

4983

28450

(3003396) Base excess in Arterial blood by calculation

1540

3756

4.02

307.65

9.9

6.0

mmol/l

1.1

0.7

2.82

1287

3015

(3001604) Monocytes [#/volume] in Blood

5527

27692

2.68

307.65

7.9

5.8

e9/l

0.7

0.6

81.04

4797

23618

(3013115) Eosinophils [#/volume] in Blood

5763

28801

2.79

307.65

8.4

5.9

e9/l

0.2

2.69

5065

24891

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2502

9201

2.81

307.65

3.9

2.7

e6/l

2.9

1.8

4.74

1614

4876

(3052851) Hemolysis interference index of Serum or Plasma

804

1388

5.36

307.65

5.5

2.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

6271

29170

3.42

307.65

6.7

3.4

mmol/l

7.0

6.1

159.75

5919

27273

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

936

1661

5.27

307.65

1.9

1.7

g/l

1.6

1.5

3.38

812

1400

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3132

10218

3.43

307.65

2.7

1.9

mg/l

3.5

2.8

29.95

2589

8510

(3024561) Albumin [Mass/volume] in Serum or Plasma

4554

21998

2.48

307.65

6.0

4.4

g/l

34.3

36.0

67.08

4238

20322

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2680

6787

4.33

307.65

4.8

3.9

mmol/l

0.8

3.54

2493

6293

(3042936) Bacteria identified in Isolate by Culture

2025

6838

2.97

307.65

2.6

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

3304

14053

2.56

307.65

6.7

3.5

82.0

94.5

118.74

3255

13766

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4347

10084

5.93

307.65

4.0

1.9

ng/l

1918.4

600.7

49.32

3456

8315

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1271

2400

5.11

307.65

3.6

1.8

ng/l

472.8

96.2

48.57

1174

2141

(3022217) INR in Platelet poor plasma by Coagulation assay

2150

4270

5.30

307.65

31.8

7.4

inr

1.8

1.1

18.19

105

841

(3026782) Osmolality of Urine

2703

10189

2.79

307.65

3.6

2.4

mosm/kgh2o

561.1

576.1

2.78

2390

8642

(3020682) Albumin/Creatinine [Ratio] in Urine

4230

9626

5.95

307.65

4.7

2.3

mg/mmol

16.6

7.5

1.53

2734

5047

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1297

3315

3.74

307.65

5.8

3.6

ng/l

110.3

74.2

27.20

1161

2913

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1076

2500

4.05

307.65

2.2

1.6

ug/l

11.0

5.3

6.31

848

2125

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1121

2117

5.03

307.65

7.4

5.6

mmol/l

24.6

24.1

3.38

1074

1942

(3037467) Urinalysis macro (dipstick) panel - Urine

6625

39710

2.39

307.65

5.5

3.5

—

(3009508) Creatinine [Moles/volume] in Urine

4113

10028

5.41

307.65

4.0

2.2

mmol/l

8.1

8.3

1.26

3105

8522

(3019309) Folate [Moles/volume] in Red Blood Cells

2697

7728

3.79

307.65

1.9

1.6

nmol/l

790.6

1144.9

95.31

2027

5630

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5640

26026

3.08

307.65

11.0

5.6

mmol/l

1.2

17.78

5104

21912

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8202

54396

2.96

307.65

5.9

3.7

mu/l

2.2

2.3

0.10

7329

48911

(3023368) Bacteria identified in Blood by Culture

3733

12440

3.58

307.65

6.0

3.7

—

(3019198) Lymphocytes [#/volume] in Blood

5639

28577

2.68

307.65

8.0

5.8

e9/l

1.9

2.0

0.72

5031

24820

(42870588) Differential panel, method unspecified - Blood

4729

18349

3.39

307.65

7.7

6.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3737

13590

3.23

307.65

2.9

2.2

—

(3032080) INR in Blood by Coagulation assay

4910

17547

3.87

307.65

10.1

3.6

inr

1.4

1.1

24.13

476

4999

(3019069) Monocytes/100 leukocytes in Blood

5723

26294

3.14

307.65

8.4

6.2

8.6

8.8

5.41

5308

24636

(3019225) pH of Specimen

2329

5432

4.55

307.65

4.6

3.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4441

20220

2.65

307.65

3.8

2.3

ug/l

175.2

156.8

0.74

4012

18721

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3399

15294

2.41

307.65

2.9

2.3

u/l

56.5

62.2

4.60

3092

14068

(3012516) Albumin [Mass/volume] in Urine

3882

9173

5.42

307.65

4.0

2.1

mg/l

123.4

734.7

13.08

2542

4809

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2795

2581

12.72

307.65

4.7

4.6

mmol/l

1.3

0.13

2222

1881

(3002030) Lymphocytes/100 leukocytes in Blood

5814

27148

3.12

307.65

8.3

6.0

25.5

29.3

108.30

5342

25271

(3027801) Oxygen [Partial pressure] in Arterial blood

1550

3760

4.04

307.65

9.9

6.0

kpa

10.6

14.0

105.20

1456

3629

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

342

216

14.12

307.65

2.2

1.4

nmol/l

1.1

0.8

2.72

258

203

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2381

7205

3.45

307.65

5.8

2.2

ng/l

1015.0

294.3

1.23

2067

5175

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2151

5287

4.23

307.65

3.8

2.1

20.2

25.6

54.56

2034

4649

(3009343) pH of Capillary blood

2869

2664

12.78

307.65

4.7

4.6

7.4

0.25

292

(3002032) Base excess in Venous blood by calculation

1444

3617

3.87

307.65

7.2

4.5

mmol/l

2.1

1.7

2.37

1241

2924

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2248

5689

4.14

307.65

3.5

2.0

g/l

2.3

3.54

2067

5270

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5764

27371

3.02

307.65

7.1

6.5

umol/l

12.6

12.1

1.17

5465

25998

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

803

900

8.30

307.65

1.7

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2833

10861

2.77

307.65

1.7

1.4

nmol/l

19.7

21.1

4.42

2308

9011

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2714

10120

2.82

307.65

2.5

1.6

mg/l

1.3

1.1

2.17

2054

7839

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

803

900

8.30

307.65

1.7

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

916

1898

4.49

307.65

2.1

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3398

7479

5.50

307.65

5.4

3.7

29.6

31.7

21.22

2661

4541

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

735

1161

5.83

307.65

3.3

2.0

ug/l

399.9

389.3

0.05

705

1074

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3545

15817

2.47

307.65

3.3

3.0

u/l

38.7

32.7

2.12

3337

15109

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1550

3763

4.04

307.65

9.9

6.0

kpa

5.3

5.1

6.89

1465

3631

(3020779) Urea [Moles/volume] in Serum or Plasma

1810

3482

5.28

307.65

11.2

6.6

mmol/l

11.4

8.4

41.54

1692

3350

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1951

5944

3.29

307.65

3.3

2.0

30.8

29.1

25.26

1909

5807

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7492

45575

2.85

307.65

10.0

6.8

u/l

83.7

79.1

11.26

6979

42674

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4462

16741

3.41

307.65

4.5

2.1

ng/l

53.8

25.3

4.54

3381

10281

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5447

23583

3.27

307.65

9.7

5.1

mmol/l

1.2

6.99

4829

21117

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4434

22326

2.32

307.65

2.8

2.1

nmol/l

76.5

79.7

10.62

3740

20050

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1441

3619

3.86

307.65

7.2

4.5

kpa

6.1

5.8

13.56

1380

3540

(3022096) Basophils/100 leukocytes in Blood

5562

25322

3.10

307.65

8.2

6.1

0.6

0.7

35.03

5125

23628

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1371

2071

6.49

307.65

10.3

8.3

mmol/l

24.8

24.3

5.77

1288

1967

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2252

6622

3.52

307.65

2.3

1.6

—

(3018010) Neutrophils/100 leukocytes in Blood

5775

26730

3.14

307.65

7.9

5.8

59.5

55.5

101.04

5338

25040

(3006315) Basophils [#/volume] in Blood

5554

27809

2.69

307.65

7.9

5.8

e9/l

0.0

0.78

4819

23691

(3027945) Reticulocytes/100 erythrocytes in Blood

1665

5055

3.22

307.65

2.7

2.9

1.9

1.6

21.11

1452

4521

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5411

19220

4.24

307.65

2.4

1.7

pmol/l

98.7

97.6

0.74

3069

9450

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2874

2697

12.65

307.65

4.7

4.6

kpa

5.2

5.0

20.93

2694

2513

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1193

2433

4.68

307.65

1.9

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2363

5513

4.57

307.65

8.7

5.6

mmol/l

1.1

1.0

7.70

2188

5149

(4146454)

497

100

45.13

307.65

2.7

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1326

3514

3.61

307.65

11.7

6.7

mmol/l

1.4

1.2

4.12

1218

3372

(3044640) Blood type and Crossmatch panel - Blood

4429

17730

3.13

307.65

3.2

2.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

928

709

12.38

307.65

4.0

3.1

u/ml

0.3

0.98

564

296

(3013512) EKG study

4644

15171

4.15

307.65

5.2

2.5

—

(3000991) Gas panel - Venous blood

1501

3654

4.01

307.65

13.6

7.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3602

13266

3.14

307.65

2.5

1.7

u/l

204.3

202.6

0.03

3418

12354

(3006504) Eosinophils/100 leukocytes in Blood

5698

26126

3.14

307.65

8.1

6.0

2.8

3.0

10.86

5259

24363

(3022948) Iron [Moles/volume] in Serum or Plasma

2345

6266

3.94

307.65

3.6

2.1

umol/l

12.0

17.8

1.12

2199

5806

(3027456) Digoxin [Moles/volume] in Serum or Plasma

367

42.69

307.65

3.7

2.1

nmol/l

0.8

0.9

0.83

297

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2546

1908

15.26

307.65

4.6

5.0

mmol/l

24.9

24.4

12.45

2397

1793

(3026493) Urate [Moles/volume] in Serum or Plasma

3526

14636

2.70

307.65

3.6

2.3

umol/l

6052.8

4965.7

0.59

2884

12925

(3022313) Gas panel - Capillary blood

2718

2058

15.45

307.65

4.5

4.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

837

1720

4.50

307.27

1.9

1.6

—

(3013707) Erythrocyte sedimentation rate by Westergren method

7017

44058

2.36

297.05

5.4

3.5

mm/h

15.2

10.6

89.33

6404

40443

(3024354) Oxygen [Partial pressure] in Venous blood

1143

3035

3.55

294.96

6.0

4.2

kpa

5.1

4.7

5.99

1074

2951

(3016502) Oxygen saturation in Arterial blood

1192

3270

3.44

292.54

11.1

6.5

93.5

96.3

26.82

1156

3175

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

315

230

12.18

287.91

2.1

2.2

ug/min

112.2

86.9

0.41

191

125

(3031040) Bacteria [#/volume] in Urine by Automated count

6186

37120

2.21

287.65

5.6

3.5

e6/l

3468.0

1263.5

0.43

554

(3014576) Chloride [Moles/volume] in Serum or Plasma

1595

5294

2.91

283.95

10.8

6.5

mmol/l

104.1

104.7

5.01

1584

5194

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6809

42735

2.26

278.91

4.4

3.4

pmol/l

14.8

14.7

1.19

6034

38386

(3007853) Bacteria identified in Skin by Aerobe culture

1613

5462

2.86

276.28

2.3

1.5

—

(40758558) Short blood count panel - Blood

3157

14705

2.26

274.91

9.1

7.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1381

4351

3.03

268.78

2.3

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8306

57414

2.74

264.32

9.4

3.3

mmol/mol

43.0

36.7

307.65

7608

52238

(40768797) Stomach Pathology biopsy report

1725

6207

2.70

262.18

1.3

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1404

4528

2.96

261.82

2.4

g/l

0.2

3.76

1293

4303

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1071

2946

3.40

260.47

1.8

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1604

5653

2.73

253.15

3.1

umol/l

8.4

8.7

0.25

1454

5014

(4010399)

1211

3687

3.09

249.02

1.5

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1227

3785

3.06

246.58

2.1

2.8

nmol/l

339.3

365.7

4.37

1098

3550

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

663

1362

4.43

242.27

1.6

1.5

iu/ml

8.5

11.3

0.40

(3037121) Protein [Mass/volume] in Urine

783

1839

3.91

239.75

3.4

4.0

g/l

0.4

0.3

3.18

338

920

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

3858

20344

2.06

236.38

4.8

2.9

—

0.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

238

150

14.00

236.32

1.1

iu/ml

40.1

19.8

0.21

(3024891) Influenza virus A+B Ag [Presence] in Specimen

659

1385

4.33

233.81

1.5

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

3393

17187

2.08

230.42

4.8

2.9

e6/l

51.1

92.6

1.82

2776

12831

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1308

4341

2.85

229.81

2.4

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1236

3980

2.92

229.45

2.3

3.0

g/l

66.0

67.0

3.79

1088

3657

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4629

26287

1.99

228.07

3.8

3.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

425

625

6.09

225.09

2.5

2.7

umol/l

34.8

35.8

0.31

371

528

(3024928) Oxygen saturation in Venous blood

437

662

5.92

224.70

4.0

5.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

416

604

6.16

223.09

2.2

1.8

mg/l

23.4

26.8

0.50

126

150

(3019060) Gas panel - Arterial blood

705

1641

3.92

218.10

2.8

2.9

—

(3000034) Microalbumin [Mass/volume] in Urine

271

242

9.91

217.26

3.8

1.9

mg/l

34.6

28.4

0.23

200

144

(3015235) Bicarbonate [Moles/volume] in Capillary blood

486

868

5.03

209.42

4.2

3.7

mmol/l

24.8

24.6

0.47

440

759

(3023520) Reticulocytes [#/volume] in Blood

1144

3724

2.87

207.17

2.5

2.9

e9/l

72.7

65.3

7.01

827

2732

(3018095) Leukocytes [#/volume] in Urine

3727

20149

1.97

205.41

5.8

3.3

e6/l

62.9

78.9

1.26

2875

13908

(3036489) Thrombin time

624

1389

4.07

204.90

3.2

2.6

22.2

21.3

2.50

591

1233

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

813

2229

3.34

196.91

1.8

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8649

63341

2.66

196.08

26.4

9.7

mg/l

24.5

25.3

1.12

7756

46469

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

545

1155

4.25

190.68

3.6

3.2

216.4

178.6

14.48

525

1094

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

141

28.03

187.36

2.2

1.3

ug/min

155.6

16.5

1.54

(3004588) Protein electrophoresis panel - Serum or Plasma

1023

3312

2.86

186.24

2.1

2.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

685

1746

3.57

185.34

14.1

7.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

311

416

6.63

180.06

1.5

1.4

e6/l

53699.8

59866.8

0.12

225

253

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

547

1216

4.05

179.55

3.5

3.1

g/l

3.9

3.4

6.25

520

1164

(3026008) Bacteria identified in Urine by Culture

2732

13834

1.98

176.32

3.5

2.6

—

(3022689) Creatine [Moles/volume] in Urine

156

17.29

172.51

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

317

453

6.21

172.37

1.5

1.4

e6/l

2609.9

3465.4

0.29

238

325

(3007164) IgA [Mass/volume] in Serum or Plasma

2102

9772

2.09

171.06

1.6

1.4

g/l

2.6

2.3

3.98

1201

5926

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

559

1309

3.85

170.74

3.6

3.0

90.2

92.0

0.86

544

1214

(3030467) Casts [#/volume] in Urine by Automated count

2985

15751

1.92

169.36

4.7

2.8

e6/l

0.6

0.3

5.73

2359

11448

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

816

2467

3.02

167.26

14.8

7.7

0.5

0.7

18.66

810

2454

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1426

5734

2.34

165.45

1.9

1.4

1.5

1.3

19.39

1189

5182

(3012441) Differential panel - Pleural fluid

295

411

6.35

164.33

1.5

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

502

1119

4.03

163.98

1.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

349

577

5.37

163.46

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2094

9871

2.06

163.24

3.8

2.6

e6/l

1.0

0.08

1202

5519

(3002173) Hemoglobin [Mass/volume] in Arterial blood

944

3136

2.77

162.93

13.2

6.5

g/l

120.9

122.8

1.86

936

3029

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

348

577

5.36

162.48

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

346

573

5.36

161.75

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

347

577

5.34

161.50

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

348

589

5.25

158.86

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

315

487

5.73

158.29

1.5

1.3

g/l

30.4

38.3

15.64

253

454

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

344

580

5.27

157.69

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

654

1799

3.29

156.70

2.2

2.4

g/l

3.3

3.0

11.09

478

1439

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

675

1894

3.23

156.62

2.2

2.3

g/l

4.0

3.7

1.79

475

1397

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

675

1897

3.22

156.21

2.2

2.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

314

491

5.67

155.94

8.0

5.5

mg/l

11.0

0.06

282

454

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

675

1900

3.22

155.79

2.2

2.3

g/l

7.7

7.1

10.54

498

1474

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

614

1631

3.40

155.44

2.3

2.5

g/l

0.9

1.0

0.10

532

1406

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

565

1428

3.56

154.29

2.4

2.3

g/l

0.0

0.34

507

1329

(3017732) Neutrophils [#/volume] in Blood

1081

3960

2.52

153.13

3.4

2.5

e9/l

4.4

3.9

6.59

730

3116

(3045788) Cell count panel - Pleural fluid

261

345

6.68

152.68

1.6

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

8835

67049

2.56

150.91

30.5

10.0

mmol/l

139.7

139.9

8.45

8610

64818

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

790

2483

2.90

150.69

15.0

7.6

1.3

1.2

0.73

783

2470

(3037522) Nuclear Ab [Titer] in Serum

1577

6857

2.17

150.59

1.4

1.3

titre

440.1

558.9

2.35

341

1424

(3009445) Proteinase 3 Ab [Units/volume] in Serum

704

2079

3.07

149.83

1.5

1.7

u/ml

10.7

13.2

0.23

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1219

4779

2.37

148.80

3.1

2.3

u/l

36.1

52.4

1.31

1032

4208

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

583

1541

3.41

148.62

2.5

2.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

8849

67388

2.54

146.14

31.1

10.1

mmol/l

4.0

33.26

8601

65004

(3027923) C peptide [Moles/volume] in Serum or Plasma

115

22.80

142.57

1.7

2.1

nmol/l

1.6

1.5

0.21

(3051611) Lipemic interference index of Serum or Plasma

310

525

5.23

141.34

5.7

3.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

8339

62170

2.13

140.85

23.4

9.3

ml/min/173m2

76.8

81.1

54.25

7597

49932

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

289

463

5.52

139.87

3.5

3.8

—

(3000494) Fungus identified in Specimen by Culture

1502

6582

2.15

139.77

1.8

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

448

1060

3.77

134.45

1.8

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

401

879

4.06

133.70

1.7

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

546

1487

3.30

132.54

2.3

g/l

35.9

38.7

17.94

462

1297

(36304419) Bacteria [Presence] in Urine

2787

15378

1.79

130.43

4.7

2.8

—

(3016244) Insulin [Units/volume] in Serum or Plasma

195

226

7.57

127.96

3.2

3.0

mu/l

45.5

17.2

9.15

188

215

(3015377) Calcium [Moles/volume] in Serum or Plasma

3252

18877

1.73

126.83

3.4

3.8

mmol/l

2.4

2.07

2495

16523

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

167

170

8.60

121.55

2.2

1.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

410

980

3.72

121.16

1.5

1.3

—

(3044927) Protein electrophoresis panel - Urine

264

445

5.23

120.93

1.2

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

491

1327

3.31

120.49

2.4

g/l

0.0

0.50

434

1232

(3005719) IgG [Mass/volume] in Serum or Plasma

962

3735

2.36

118.69

2.9

2.8

g/l

10.3

10.4

0.11

879

3435

(3000850) Epithelial cells [#/volume] in Urine

2169

11367

1.83

118.55

3.4

2.3

e6/l

5.1

4.6

1.10

1807

9866

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

485

1315

3.30

118.39

2.4

g/l

0.0

0.00

434

1229

(3028026) IgM [Mass/volume] in Serum or Plasma

801

2864

2.54

118.15

1.9

2.0

g/l

1.2

1.4

1.05

707

2638

(3045424) Erythrocytes [Presence] in Urine

410

998

3.66

117.98

1.7

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1865

9343

1.89

117.37

1.5

pmol/l

400.7

42006672.3

10.12

1470

7706

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

580

1769

2.94

116.07

2.2

2.4

g/l

10.5

10.3

0.41

500

1520

(3004616) Nuclear Ab [Presence] in Serum

311

635

4.33

113.62

1.3

—

(40768806) Pleura Pathology biopsy report

254

438

5.11

113.44

1.4

1.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

171

202

7.41

110.41

1.1

u/ml

3.6

6.7

0.69

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

549

1671

2.94

110.17

1.5

1.6

titre

228.0

300.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

21.87

107.45

14.7

6.6

mmol/l

5.4

5.2

0.28

(3028707) Methadone [Presence] in Urine by Screen method

153

164

8.16

106.98

2.4

2.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

494

1444

3.06

106.33

2.8

3.8

mg/l

53.0

45.4

0.38

452

1196

(3034860) Kappa light chains.free [Mass/volume] in Serum

494

1450

3.04

105.57

2.8

3.8

mg/l

77.9

42.0

1.94

450

1192

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8170

62008

1.87

105.18

5.6

3.2

mmol/l

1.6

1.2

194.77

7347

56330

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

480

1398

3.06

103.93

2.7

3.7

ratio

5.6

2.7

0.29

111

(3017143) Hepatitis C virus Ab [Presence] in Serum

1159

5120

2.08

103.46

1.8

1.5

—

(3051651) Icteric interference index of Serum or Plasma

192

277

6.08

103.31

6.9

3.6

—

(3000492) Spirometry study

1241

5631

2.03

103.01

1.8

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

437

1219

3.19

101.70

1.5

1.3

ug/g

263.3

280.6

0.85

260

720

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

219

365

5.27

101.53

3.1

2.4

—

(40768804) Tissue Pathology biopsy report

4147

26765

1.59

100.07

2.2

2.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

288

618

4.11

98.62

3.1

4.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

596

2022

2.64

97.34

5.0

3.6

g/l

128.3

130.5

1.24

585

1996

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

391

1055

3.29

95.99

1.4

1.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8213

62904

1.83

95.29

6.6

3.5

mmol/l

6.4

5.6

307.65

7199

57080

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

138

152

7.93

94.42

2.4

2.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

615

2151

2.57

94.40

2.5

1.9

u/l

37.6

40.6

2.92

516

1953

(3014271) Vancomycin [Susceptibility]

148

179

7.23

93.66

2.9

2.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

802

3202

2.26

91.85

1.4

1.3

u/ml

227.9

277.2

0.87

751

2986

(40761511) CBC panel - Blood by Automated count

8686

67999

1.99

89.90

22.4

8.4

—

(3051593) INR in Capillary blood by Coagulation assay

12.53

89.17

3.1

3.8

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

17.38

88.85

1.2

1.5

nmol/l

1.3

1.5

0.46

(3036782) Glucose [Moles/volume] in Pleural fluid

194

333

5.11

87.08

1.3

mmol/l

7.0

5.2

8.03

174

299

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1204

5725

1.93

86.43

1.8

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

188

317

5.20

86.06

2.0

1.8

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

147

195

6.59

85.68

1.4

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

147

195

6.59

85.68

1.4

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

207

382

4.75

85.53

1.2

1.3

titre

138.1

181.6

0.38

(3030981) Hyaline casts [#/volume] in Urine by Automated count

742

2957

2.26

85.16

3.5

2.5

e6/l

0.2

0.08

730

2878

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

206

382

4.73

84.63

1.2

1.3

titre

60.0

47.9

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

485

1590

2.72

84.52

4.1

3.6

0.6

0.7

3.84

480

1496

(3028626) Oxygen [Partial pressure] in Capillary blood

431

1330

2.88

84.10

12.3

5.9

kpa

8.3

9.0

10.10

409

1257

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1952

10825

1.70

83.75

1.3

1.2

u/ml

2.3

0.03

290

2891

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

669

2580

2.33

82.84

3.0

3.5

pmol/l

4.4

4.6

5.96

577

2321

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

418

1291

2.87

81.42

2.8

1.9

mg/l

13.6

10.6

10.26

379

1215

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

244

539

3.98

80.36

1.7

—

(36660697) Celiac disease serology panel - Serum

895

3943

2.06

79.45

1.2

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

419

1321

2.81

78.56

1.7

1.5

g/l

0.2

3.12

385

1254

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

183

328

4.89

78.23

1.3

u/l

950.8

555.0

0.47

171

313

(3009466) Valproate [Moles/volume] in Serum or Plasma

190

353

4.72

77.89

6.5

3.4

umol/l

353.0

370.6

0.72

164

278

(3034770) Mitochondria Ab [Titer] in Serum

374

1118

2.96

77.20

1.2

1.3

titre

2067.8

912.3

—

(4015189)

106

108

8.55

77.11

2.5

3.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

253

592

3.76

76.93

1.4

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1712

9377

1.70

76.06

1.3

1.2

iu/ml

42.2

44.3

0.12

428

3098

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

319

877

3.21

75.90

1.3

1.2

titre

123.3

140.7

—

(3021589) Normoblasts [#/volume] in Blood

3968

26452

1.50

75.47

11.3

8.2

e9/l

0.0

0.19

3115

21526

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

423

1370

2.74

75.37

1.7

1.5

g/l

1.2

5.48

390

1306

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

225

491

4.02

75.33

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1354

6959

1.79

75.26

1.9

1.6

—

(3037756) Immunofixation for Serum or Plasma

340

985

3.05

74.10

1.6

1.9

—

(3003338) MCHC [Mass/volume]

5745

57174

0.67

72.88

34.0

12.0

g/l

329.7

333.6

125.75

5682

56769

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

671

2734

2.20

72.67

2.8

2.3

—

(3048689) Calprotectin [Mass/mass] in Stool

1245

6303

1.81

72.59

2.2

2.4

ug/g

156.9

137.7

0.72

910

5018

(3018851) Theophylline [Moles/volume] in Serum or Plasma

25.56

72.19

2.8

1.4

umol/l

48.3

40.9

0.47

(3007566) Smooth muscle Ab [Titer] in Serum

368

1135

2.87

71.80

1.2

1.3

titre

71.6

189.1

1.12

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

148

237

5.45

71.65

1.4

1.5

—

(40761536) Microorganisms panel - Urine sediment

129

4655

0.23

70.78

4.6

3.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

149

243

5.36

70.75

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

209

460

3.98

69.18

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4111

27926

1.47

69.17

5.0

4.9

ug/l

2.5

3.3

2.48

3491

25697

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

408

1367

2.64

68.00

1.5

—

(3045414) Leukocytes [Presence] in Urine

636

2604

2.18

67.96

1.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

183

370

4.33

67.68

2.0

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

420

1444

2.58

66.45

2.0

1.8

ug/l

1.1

2.2

1.46

348

1285

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

12.33

66.10

12.7

8.0

mmol/l

0.6

0.5

0.69

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8846

70856

1.89

65.74

15.5

8.1

u/l

31.2

25.9

24.72

8477

67867

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8237

64665

1.66

65.73

6.2

3.6

mmol/l

1.3

1.5

307.65

7415

59161

(3004809) Band form neutrophils/100 leukocytes in Blood

292

831

3.09

65.58

3.0

3.5

1.5

1.6

0.08

247

641

(4306422)

219

520

3.69

65.23

1.2

—

(3022145) Colonoscopy Study observation

1297

6845

1.73

65.05

1.4

1.3

—

(4198724)

13.43

63.52

1.8

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

207

482

3.76

63.40

1.3

1.4

u/l

24.5

34.2

3.47

165

399

(40760888) Immunoglobulin light chains.free panel - Serum

341

1080

2.79

63.32

2.8

3.8

—

(3049717) Cytology report of Urine Cyto stain

559

2238

2.22

63.02

2.6

2.9

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

288

833

3.04

62.92

2.0

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

390

1330

2.59

62.71

1.4

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

266

736

3.18

62.61

1.3

1.4

u/l

34.5

38.4

0.16

215

629

(3021879) Hepatitis B virus core Ab [Presence] in Serum

785

3583

1.97

62.58

1.5

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8272

65210

1.65

62.16

6.1

3.6

mmol/l

4.4

5.0

307.65

7611

59862

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8391

66395

1.67

62.07

6.4

3.9

mmol/l

2.6

3.1

307.65

7545

60544

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

218

540

3.54

61.04

1.4

1.2

u/ml

4.9

4.2

0.35

256

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1564

8851

1.62

59.74

1.3

1.2

u/ml

18.1

14.6

0.61

374

3513

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

12.00

59.58

1.4

1.2

ng/l

203.6

144.0

0.37

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

129

216

5.21

59.57

1.8

2.1

—

(3038026) Centromere Ab [Units/volume] in Serum

187

425

3.85

59.27

1.2

u/ml

2.6

44.8

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

444

1653

2.38

59.23

6.9

5.5

mg/l

1.7

1.3

19.46

409

1540

(3023419) Bacteria identified in Sputum by Culture

196

462

3.71

59.01

3.0

2.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

321

1023

2.76

58.91

9.3

5.0

iu/ml

957.2

2132.7

0.31

135

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

375

1303

2.54

58.01

1.2

1.3

u/ml

6.9

7.2

0.04

214

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

145

276

4.58

57.81

1.2

1.3

u/l

15.0

16.0

0.15

136

269

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

183

417

3.84

57.80

1.2

u/ml

91.7

89.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

126

213

5.16

57.58

1.8

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

126

213

5.16

57.58

1.8

2.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

183

419

3.82

57.41

1.2

u/ml

72.1

32.3

0.89

(3000475) Leukocytes [#/volume] in Synovial fluid

381

1341

2.51

57.38

1.6

e6/l

19696.5

10871.0

2.01

292

957

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

177

396

3.91

57.34

1.1

1.2

u/ml

6.1

2.8

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

267

785

2.99

56.71

5.2

3.5

u/ml

552.9

16223.3

0.82

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

369

1290

2.53

56.36

1.2

1.3

u/ml

2.7

3.9

0.29

140

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

459

1787

2.28

55.23

1.6

1.7

—

(3042733) HLA Ab [Presence] in Serum

121

6.68

55.23

5.2

4.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

322

1063

2.67

55.21

1.2

u/ml

1.6

5.4

0.92

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

385

1388

2.45

55.09

1.2

u/ml

73.3

42.9

0.51

102

(3029937) Albumin [Presence] in Urine by Test strip

1124

15040

0.60

55.05

3.5

3.3

estimate

0.0

1.46

276

4888

(3003181) Sodium [Moles/volume] in Urine

235

653

3.16

54.94

1.6

mmol/l

69.7

67.1

0.30

179

525

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

115

188

5.33

54.52

1.3

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

208

542

3.36

53.93

3.0

3.7

60.2

56.8

1.21

169

347

(3020491) Glucose [Moles/volume] in Blood

148

306

4.22

53.25

1.5

1.3

mmol/l

8.1

6.0

4.85

215

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

201

517

3.40

53.18

1.2

1.1

116.0

116.8

0.09

193

456

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

308

1027

2.64

51.78

2.0

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

134

262

4.46

51.73

1.8

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

134

262

4.46

51.73

1.8

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

134

262

4.46

51.73

1.8

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

134

262

4.46

51.73

1.8

2.0

—

(44806420)

16.97

51.60

2.1

1.8

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

18.56

51.39

8.7

9.1

68.9

46.5

1.27

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

392

1474

2.35

51.09

1.5

1.7

—

(4024509)

188

477

3.45

50.80

1.7

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

107

175

5.32

50.72

2.3

3.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

301

1003

2.64

50.67

2.1

1.6

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

7.84

50.43

1.2

1.3

pmol/l

251.8

327.9

0.56

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

206

557

3.24

50.38

1.2

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

221

625

3.10

50.19

1.1

g/l

1.6

1.4

3.14

187

585

(37021550) Renin [Units/volume] in Plasma --upright

8.32

50.05

1.2

1.3

mu/l

68.9

52.2

0.34

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

192

499

3.37

50.00

1.2

u/l

54.1

74.4

1.89

114

338

(3033705) Calcium.ionized [Moles/volume] in Venous blood

174

424

3.59

49.96

3.0

1.8

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

137

281

4.25

49.82

1.0

1.1

mg/l

282.2

286.1

0.23

114

267

(3009214) Lutropin [Units/volume] in Serum or Plasma

358

1309

2.41

49.66

1.4

1.5

u/l

8.2

8.9

0.49

283

1024

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

7.91

49.46

1.8

1.3

umol/l

93.6

125.5

0.24

(3035285) Chloride [Moles/volume] in Venous blood

174

427

3.56

49.45

3.0

1.8

mmol/l

105.9

105.4

0.65

174

422

(3041354) Potassium [Moles/volume] in Venous blood

174

428

3.55

49.28

3.0

1.8

mmol/l

4.1

4.0

0.67

174

423

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

379

1428

2.34

49.17

1.5

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

158

372

3.71

47.70

1.2

1.5

titre

—

(3037556) Urate [Mass/volume] in Serum or Plasma

132

5.86

46.70

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

252

802

2.76

46.38

1.5

1.6

g/l

0.7

0.9

2.90

219

607

(1761482) Bacteria [#/volume] in Urine by Culture

338

1258

2.36

45.07

4.1

3.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1113

6188

1.62

44.67

2.8

2.0

nmol/l

12.1

13.8

11.73

955

5645

(3021901) Oxygen saturation in Capillary blood

208

612

2.97

44.17

4.5

3.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

815

4194

1.74

43.80

2.5

2.4

au/ml

19.8

24.7

0.52

295

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

227

706

2.82

43.63

1.3

—

(3006462) Nitrate [Presence] in Urine

112

218

4.47

43.53

3.8

2.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

146

5.36

43.08

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

293

1045

2.46

42.90

1.9

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

195

563

3.03

42.80

1.4

1.2

u/ml

3.3

4.1

0.25

217

(3001964) Herpes simplex virus Ag [Presence] in Specimen

171

4.88

41.46

1.9

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

112

228

4.27

41.18

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

137

324

3.68

41.15

3.1

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

163

4.96

40.91

41.7

36.1

ug/l

6.9

7.0

0.03

143

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

145

359

3.52

40.73

1.2

mmol/l

2.1

1.9

1.26

136

343

(40760892) CBC W Ordered Manual Differential panel - Blood

960

12534

0.62

40.63

4.3

4.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

192

569

2.95

40.29

1.2

1.3

nmol/l

0.1

0.2

—

(21494755) Public health laboratory ask at order entry panel

501

7735

0.53

40.20

1.4

—

(4211845)

114

240

4.13

40.15

3.8

2.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

206

638

2.82

39.93

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

515

2367

1.93

39.85

2.2

1.4

mg/l

4.8

2.7

4.55

453

1500

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

192

573

2.93

39.80

1.2

1.3

nmol/l

0.6

2.6

0.51

177

553

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

286

1047

2.40

39.58

1.8

1.4

u/ml

22.8

11.1

—

(1761868) Lipid panel - Serum or Plasma

2320

25448

0.72

39.36

3.1

2.3

—

(3011288) Drugs identified in Urine by Screen method

175

499

3.06

39.27

2.7

1.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

149

386

3.37

39.07

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

943

5197

1.63

38.94

1.6

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

7.15

38.59

1.7

2.0

—

(3021788) Differential panel - Synovial fluid

280

1029

2.39

38.43

1.6

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

484

2207

1.94

38.32

2.0

1.6

nmol/l

34.5

42.6

15.85

460

2164

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

116

257

3.93

38.19

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

144

371

3.38

38.10

2.4

3.0

e9/l

0.3

0.04

128

300

(3010375) cycloSPORINE [Mass/volume] in Blood

109

231

4.10

38.08

35.7

27.6

ug/l

129.5

117.5

0.82

206

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

122

281

3.78

38.07

1.2

1.3

u/l

149.9

74.0

1.58

114

243

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

120

274

3.81

37.91

1.2

1.3

u/l

40.0

18.4

3.07

110

228

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

362

1499

2.12

37.37

2.1

1.8

pmol/l

196.5

215.8

3.00

336

1440

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

146

388

3.28

36.80

2.4

2.9

e6/l

589.5

538.6

0.32

130

307

(3035320) C reactive protein [Mass/volume] in Body fluid

142

374

3.31

36.31

2.5

2.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

725

3799

1.70

36.29

1.4

1.3

au/ml

40.5

53.7

0.79

221

(3018418) pH of Serum or Plasma

2298

15350

1.38

36.29

6.9

3.7

7.4

0.05

100

2775

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

321

1286

2.19

36.02

1.1

u/ml

4.3

7.6

1.17

213

(3025941) Bacteria identified in Stool by Culture

577

2840

1.80

35.96

1.3

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

168

493

2.97

35.91

1.2

1.3

nmol/l

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

8.49

35.64

1.2

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

253

921

2.41

35.48

1.9

g/l

134.7

132.7

0.38

121

635

(3022493) Free Hemoglobin [Mass/volume] in Plasma

178

4.44

35.22

12.7

1.4

mg/l

57.8

3332.8

1.06

128

(3037692) Legionella sp identified in Specimen by Organism specific culture

168

4.55

35.08

1.9

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

173

526

2.87

34.73

1.2

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

376

1643

2.01

33.62

5.7

2.8

mmol/l

25.4

0.11

367

1609

(21494890) Protein electrophoresis panel - 24 hour Urine

157

464

2.95

33.17

1.8

2.5

—

(3001556) Androgen free Index in Serum or Plasma

20.18

32.97

2.0

1.2

—

(3000330) Specific gravity of Urine by Test strip

535

2646

1.79

32.77

3.7

2.8

—

(3025315) Body weight

11.04

32.25

6.6

3.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

7.45

32.13

1.2

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

142

406

3.05

31.79

1.8

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

142

406

3.05

31.79

1.8

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

142

406

3.05

31.79

1.8

1.7

—

(40768446) Kidney Pathology biopsy report

197

4.06

31.77

2.1

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

332

1416

2.06

31.72

1.5

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5022

38059

1.29

31.12

2.9

2.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

782

4341

1.60

31.09

4.8

4.1

0.0

0.1

3.02

262

1155

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

119

312

3.32

30.71

1.4

1.5

umol/l

13.8

11.6

2.57

114

307

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

8.27

30.69

1.2

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2013

21930

0.74

30.64

3.7

3.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

177

4.17

30.45

2.1

3.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

260

1024

2.22

30.45

1.5

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2521

17470

1.33

30.37

3.2

3.0

ug/l

0.8

0.08

1629

11098

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

262

1042

2.20

29.97

4.3

2.8

1.6

1.5

0.57

255

988

(3028433) Virus identified in Specimen by Culture

172

4.19

29.93

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

165

532

2.70

29.75

2.1

1.4

—

(3035880) pH of Pleural fluid

177

4.12

29.65

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

13.66

29.53

3.7

1.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

153

479

2.78

29.17

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

156

494

2.75

29.12

2.4

—

(44790047)

151

470

2.80

29.11

2.1

1.4

—

(44790049)

151

470

2.80

29.11

2.1

1.4

—

(44790048)

151

470

2.80

29.11

2.1

1.4

—

(44806118)

151

470

2.80

29.11

2.1

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

113

297

3.31

29.07

1.2

1.3

titre

28.6

217.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2253

15445

1.34

29.00

1.6

1.5

mmol/l

1.6

1.3

37.97

1999

12926

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1556

10070

1.40

28.84

3.3

mmol/l

2.5

2.4

8.22

1207

8957

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

8.89

28.62

2.0

2.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

203

738

2.40

28.62

2.0

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

369

1701

1.91

28.28

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

243

962

2.21

28.13

1.9

1.5

u/ml

105.3

108.1

0.12

176

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

138

417

2.88

28.09

1.4

1.3

—

(4062490)

154

495

2.71

27.96

1.5

1.4

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

6.96

27.88

1.4

nmol/l

7.9

380400.8

1.06

(3014148) Varicella zoster virus Ab [Titer] in Serum

175

601

2.54

27.85

1.2

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

636

3449

1.63

27.75

1.2

—

(4034850)

1885

0.24

27.68

3.9

6.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

7545

60688

1.33

27.58

29.2

10.3

38.7

40.7

49.02

5498

46575

(3017181) Myelocytes/100 leukocytes in Blood

786

4492

1.55

27.48

4.8

4.0

0.8

0.9

1.04

261

1247

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

161

538

2.61

27.10

1.1

—

(3016038) Potassium [Moles/volume] in Urine

251

3.43

26.96

1.4

1.5

mmol/l

35.6

38.1

0.41

220

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

346

1587

1.91

26.92

7.6

3.3

49.8

47.3

0.97

339

1566

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

229

902

2.22

26.85

1.3

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

189

685

2.41

26.85

1.3

1.2

mmol/l

7.6

6.6

4.49

157

503

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

173

603

2.50

26.72

1.5

2.2

titre

626.7

2407.8

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

13.73

26.64

1.3

1.4

mg/l

43.1

39.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

180

642

2.45

26.48

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

181

3.88

26.48

2.5

1.8

u/ml

4461.5

4915.6

0.04

(3035947) Staphylolysin Ab [Units/volume] in Serum

222

3.56

26.27

1.2

1.1

iu/ml

3.7

3.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1134

7062

1.44

25.93

5.1

4.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

247

4165

0.50

25.81

4.6

3.3

mmol/l

1.2

0.24

231

3537

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

148

486

2.65

25.81

2.3

2.6

e6/l

728.9

652.2

0.61

167

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

110

307

3.11

25.73

1.7

1.6

u/l

3.4

5.8

0.94

160

(3028192) IgG subclass 2 [Mass/volume] in Serum

150

498

2.62

25.60

1.4

g/l

2.5

3.0

2.93

134

342

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

7.65

25.50

2.0

2.2

—

(3011985) Renin [Units/volume] in Plasma

165

576

2.50

25.42

1.3

1.5

mu/l

101.8

69.0

0.64

139

517

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

571

7613

0.62

25.41

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

149

498

2.61

25.10

1.4

g/l

7.1

7.0

0.13

127

343

(3024139) IgG subclass 3 [Mass/volume] in Serum

149

498

2.61

25.10

1.4

g/l

0.3

0.4

2.51

131

342

(3020876) Protein [Mass/time] in 24 hour Urine

117

347

2.93

24.68

1.7

2.1

g/24h

0.8

0.9

—

(3006270) Folate [Moles/volume] in Blood

125

385

2.82

24.63

1.3

1.1

nmol/l

342.0

366.4

0.56

101

343

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

100

271

3.21

24.57

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

111

322

3.00

24.34

1.3

1.5

u/ml

31.4

19.7

0.53

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

103

4.80

24.34

1.6

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

6.38

24.09

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.65

23.98

2.8

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

101

282

3.11

23.64

1.5

1.3

—

(40768443) Skin Pathology biopsy report

516

2765

1.64

23.57

1.3

1.2

—

(3011412) CD3 cells [#/volume] in Blood

154

540

2.48

23.54

2.3

2.7

e9/l

1.6

1.2

1.53

307

(4268621)

121

376

2.80

23.48

2.5

2.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

117

4.44

23.42

1.1

u/ml

8.2

9.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

6.16

23.33

1.1

—

(40757373) Influenza virus identified in Isolate

6.16

23.33

2.2

1.6

—

(3048879) Bone marrow aspiration report

160

3.85

22.99

1.3

2.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

123

4.30

22.85

1.6

ug/l

0.4

0.12

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

567

3139

1.59

22.68

1.2

iu/ml

110.6

160.0

2.55

163

1190

(3022621) pH of Urine by Test strip

633

3598

1.55

22.59

3.0

2.4

—

(3042631) Mycobacterium sp identified in Specimen

168

626

2.34

22.51

2.5

2.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

175

665

2.29

22.41

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

151

539

2.44

22.25

1.3

1.5

pmol/l

254.8

358.7

0.99

112

420

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

10.70

22.20

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

119

4.30

22.11

1.2

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

332

1603

1.81

22.04

1.2

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2036

0.35

21.84

1.5

1.6

—

(3016879) Cocaine [Presence] in Urine

237

1026

2.02

21.84

2.1

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

113

4.37

21.82

1.2

1.1

—

(3025159) Blasts/100 leukocytes in Blood

700

4099

1.51

21.77

4.9

4.1

0.0

0.4

1.54

249

985

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

117

4.30

21.73

1.2

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

9.73

21.66

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

+∞

21.64

1.2

0.0

ug/l

101.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

225

959

2.05

21.64

1.5

1.3

u/ml

274.7

261.2

0.30

149

583

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

8.37

21.62

1.6

1.5

mg/l

2.6

3.3

0.23

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

8.37

21.62

1.6

1.5

mg/l

1.0

2.7

0.87

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

8.37

21.62

1.6

1.5

mg/l

0.4

1.4

2.54

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

8.37

21.62

1.6

1.5

mg/l

1.6

1.4

0.09

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

8.37

21.62

1.6

1.5

mg/l

0.7

1.0

0.33

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

13.58

21.53

1.3

1.0

—

(4035726)

989

6205

1.42

21.50

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1013

6387

1.41

21.41

3.2

4.6

ug/l

22.7

25.6

0.10

832

5178

(3023420) DNA double strand Ab [Units/volume] in Serum

151

549

2.39

21.39

1.8

1.3

iu/ml

34.6

21.9

—

(3002385) Erythrocyte distribution width [Ratio]

5745

53713

0.81

21.32

36.3

11.9

14.2

13.5

180.64

5622

52341

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.40

21.32

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

119

4.22

21.28

1.2

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

279

1292

1.89

21.15

1.5

mg/l

653.3

518.3

0.72

259

1248

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.09

20.89

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1783

0.32

20.79

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

114

4.26

20.76

2.1

1.4

e6/l

17499.5

5996.7

0.74

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

181

3.50

20.66

2.5

umol/l

54.6

53.7

0.08

166

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

105

4.37

20.33

1.2

1.1

—

(3034426) Prothrombin time (PT)

113

4.22

20.16

1.4

1.1

—

(40762814) Titanium [Mass/volume] in Blood

113

4.22

20.16

2.2

ug/l

4.6

3.6

0.28

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

7.63

20.12

1.1

mmol/l

8.6

8.5

0.03

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

154

587

2.28

19.64

1.8

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

350

1776

1.73

19.64

1.8

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

501

2792

1.58

19.48

1.1

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

239

1082

1.93

19.43

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

686

4110

1.47

19.03

3.8

3.9

0.8

0.6

0.71

210

912

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

171

690

2.16

19.02

1.7

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

185

773

2.08

18.82

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

135

3.79

18.77

2.3

1.5

e6/l

16929.1

1784.8

0.56

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

284

2.84

18.72

1.5

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

284

2.84

18.72

1.5

1.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

156

611

2.22

18.68

2.1

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

6.70

18.63

1.7

2.9

umol/l

16.3

20.0

0.78

(3000764) Benzodiazepines [Presence] in Urine

246

1141

1.88

18.60

2.1

1.4

—

(3024932) HLA-DR beta [Type]

173

3.41

18.55

1.1

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

156

617

2.20

18.25

1.5

1.7

—

(3033799) Differential panel - Peritoneal fluid

119

3.93

18.10

2.3

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.71

18.08

8.3

5.7

—

(3007461) Platelets [#/volume] in Blood

8973

75019

1.43

18.04

36.6

13.9

e9/l

247.6

249.1

1.34

8765

72263

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

5.34

17.85

3.3

1.5

—

(3028300) Cannabinoids [Presence] in Urine

247

1163

1.85

17.84

2.1

1.4

—

(3027008) Opiates [Presence] in Urine

246

1160

1.85

17.69

2.1

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

223

1019

1.91

17.67

4.6

2.8

0.7

0.9

9.02

218

963

(3036603) Volume of Urine

106

359

2.56

17.53

1.7

1995.3

2190.8

0.21

(3017569) Oxygen content in Arterial blood

131

3.70

17.30

1.6

2.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

108

4.01

17.22

1.3

ug/l

343.2

246.3

0.19

(3035941) MCH [Entitic mass]

8974

75095

1.42

17.19

36.4

13.8

30.2

30.4

28.18

8835

73686

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

3.82

17.14

1.2

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

12.96

17.13

1.2

1.1

pmol/l

284.0

334.9

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

124

3.77

17.13

1.4

1.1

—

(3023410) Appearance of Cerebral spinal fluid

147

584

2.19

17.04

1.8

2.0

—

(3024731) MCV [Entitic volume]

8974

75112

1.42

16.98

36.5

13.8

91.0

90.9

0.81

8837

73700

(3010813) Leukocytes [#/volume] in Blood

8976

75139

1.41

16.89

36.7

13.9

e9/l

7.3

6.4

164.94

8720

72113

(3020717) Zinc [Moles/volume] in Serum or Plasma

243

2.89

16.88

1.7

umol/l

17.6

29.9

3.63

236

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.28

16.88

1.2

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

8974

75122

1.41

16.85

36.6

13.9

e12/l

4.5

4.6

28.72

8717

72108

(3024471) HLA-A [Type]

180

3.23

16.82

1.0

—

(3008295) Osmolality of Serum or Plasma

109

382

2.48

16.81

1.6

1.3

mosm/kgh2o

283.2

279.2

0.67

307

(3044941) Cell count panel - Synovial fluid

191

845

1.97

16.66

1.5

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

8975

75156

1.41

16.55

36.8

14.0

g/l

134.7

138.4

80.04

8838

73749

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

7.45

16.45

1.1

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

128

491

2.27

16.17

2.9

3.0

nmol/l

18.6

17.1

0.82

115

478

(3002256) Pathology report gross observation

1299

8865

1.30

16.17

1.3

—

(3047189) Immunofixation for 24 hour Urine

245

2.83

16.09

1.8

2.0

—

(3004775) Volume in Urine collected for unspecified duration

4.06

15.78

2.6

1.9

685.7

710.3

0.14

(3026480) Teichoate Ab [Titer] in Serum

6.97

15.56

1.0

—

(3002619) Bacteria identified in Specimen by Culture

105

3.87

15.51

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

234

1133

1.80

15.50

1.5

mmol/l

3.9

3.5

5.84

217

1090

(3014891) Appearance of Pleural fluid

6.61

15.45

1.8

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.83

15.34

1.1

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

238

2.80

15.25

1.1

u/l

18.0

18.9

0.09

185

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

239

2.79

15.13

1.1

u/l

83.9

76.8

0.46

197

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

281

2.62

14.82

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

315

1678

1.64

14.81

1.7

1.6

iu/ml

0.0

1.5

0.74

332

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

283

2.60

14.62

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

284

1478

1.68

14.61

1.2

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

289

2.58

14.53

1.0

1.1

nmol/l

2.3

9.6

0.67

(4094501)

277

1435

1.68

14.50

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

350

4610

0.64

14.50

4.1

2.2

ml/min/173m2

57.1

69.7

6.45

165

1603

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

6.69

14.42

1.9

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

5.29

14.40

1.7

2.7

mmol/l

1.1

1.5

0.52

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.36

14.35

1.1

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.85

14.11

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

284

1492

1.66

14.11

1.2

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

153

665

2.00

14.11

1.7

1.5

57.7

55.0

0.34

110

416

(3033923) Metanephrine [Moles/time] in 24 hour Urine

4.52

14.07

1.2

umol/24h

0.7

0.6

0.18

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

7.56

13.98

4.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

218

2.78

13.71

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

304

2.48

13.59

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

223

1110

1.75

13.51

1.7

1.9

iu/l

3.6

4.5

1.01

415

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

112

3.55

13.49

1.1

—

(1002224) Polysomnography panel

441

2593

1.49

13.45

1.0

1.1

—

(3010503) CD19 cells [#/volume] in Blood

343

2.38

13.39

2.0

2.8

e9/l

0.2

0.4

0.71

338

(3024263) Appearance of Synovial fluid

271

2.56

13.33

2.5

1.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

349

2.36

13.33

1.6

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

360

2.34

13.31

4.0

2.1

mmol/l

8.0

6.2

4.30

309

(3008536) Aspergillus sp Ab [Presence] in Serum

109

3.57

13.30

2.0

2.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.39

13.22

1.3

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

213

2.77

13.20

2.8

3.9

ug/l

1.5

1.4

0.14

207

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

4.01

13.17

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.05

13.01

1.5

1.2

71.3

73.9

0.08

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

168

2.99

12.95

2.3

2.4

171.2

132.3

2.14

159

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

128

3.31

12.95

1.1

109.5

110.8

0.10

117

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.88

12.94

1.4

1.1

g/l

31.9

24.7

1.76

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

9.87

12.90

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

275

1469

1.63

12.84

1.2

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

205

1018

1.75

12.56

1.2

u/ml

48.0

49.1

0.03

103

(3027944) Amphetamines [Presence] in Urine

225

1150

1.70

12.44

2.1

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

5.23

12.33

5.7

10.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

7.77

12.24

1.7

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

143

3.09

12.05

1.1

1.2

g/l

0.3

0.76

122

(3019897) Erythrocyte distribution width [Ratio] by Automated count

794

0.25

11.81

2.4

2.1

13.1

0.02

778

(3045142) Bone marrow Pathology biopsy report

162

765

1.84

11.75

1.3

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

384

4756

0.68

11.69

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

194

2.72

11.56

3.0

2.5

e6/l

253.3

504.3

0.67

104

(3010144) Erythrocytes [#/volume] in Synovial fluid

117

499

2.03

11.45

1.4

e6/l

147418.9

73046.3

0.49

354

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

17.28

11.44

1.1

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

5.02

11.38

5.8

10.0

—

(3050794) Legionella sp Ab [Presence] in Serum

5.19

11.30

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

185

921

1.75

11.28

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.74

11.09

1.5

1.3

81.9

85.4

0.11

(3017704) Immunofixation for Urine

216

2.57

10.83

1.5

1.8

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

+∞

10.82

4.8

0.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

164

801

1.78

10.70

3.2

2.9

u/ml

1185.1

390.0

0.33

164

783

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

280

2.35

10.69

1.3

1.4

u/l

5.4

5.8

0.46

238

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1074

0.38

10.68

3.8

3.4

60.3

56.4

1.43

1074

(3036670) Protein [Mass/volume] in Synovial fluid

174

2.74

10.56

1.3

g/l

40.5

40.0

0.07

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

376

2.14

10.51

1.3

1.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1027

0.38

10.48

3.7

3.2

e9/l

4.7

3.8

2.15

1027

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

141

663

1.85

10.42

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

236

2.46

10.40

1.2

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

127

578

1.91

10.38

2.3

41.1

38.8

0.31

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

119

533

1.94

10.20

1.1

1.3

—

(1616796) Gas panel - Central venous blood

151

733

1.79

10.08

5.1

2.9

—

(3044007) Cell count panel - Peritoneal fluid

115

3.08

9.75

2.6

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.40

9.71

1.5

1.2

g/l

19.2

13.0

3.20

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

153

2.77

9.67

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

7.20

9.57

1.1

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

121

3.00

9.56

2.3

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.16

9.53

1.3

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.28

9.45

2.0

1.4

—

(3019174) dRVVT (LA screen)

5.76

9.43

1.2

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

187

983

1.65

9.42

1.2

—

(21494434) Karyotype in Bone marrow

115

524

1.90

9.41

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

9.42

9.32

5.8

7.4

mmol/l

0.2

0.09

(3028679) Herpes simplex virus Ab [Presence] in Serum

244

2.34

9.27

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

110

498

1.92

9.19

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.87

9.08

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

387

2.04

9.08

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

387

2.04

9.08

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

387

2.04

9.08

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

159

2.67

9.02

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

666

7280

0.77

9.02

1.9

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

178

935

1.65

9.01

1.7

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

384

2.03

8.91

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

384

2.03

8.91

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

384

2.03

8.91

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

154

782

1.71

8.86

1.1

u/ml

6.2

4.2

0.42

400

(3047007) Chlamydophila sp Ab [Presence] in Serum

173

909

1.65

8.76

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

370

2.04

8.70

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

296

2.17

8.66

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

367

2.03

8.53

1.4

1.3

u/ml

0.7

2.1

1.09

151

(3044009) aPTT.lupus sensitive (LA screen)

5.18

8.49

1.2

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

3.21

8.40

1.0

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

337

2077

1.41

8.16

3.3

3.9

u/ml

1965.8

1516.0

0.09

294

1812

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

392

1.97

8.11

1.2

mg/l

66.1

44.1

0.51

330

(40768441) Liver Pathology biopsy report

429

1.92

8.05

1.3

1.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

4.69

8.05

1.1

u/l

18.0

22.9

0.60

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.46

8.01

1.2

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

255

1501

1.48

7.89

1.2

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

147

2.59

7.71

1.3

1.9

—

(3022670) pH of Venous cord blood

4.32

7.71

1.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

142

2.62

7.71

1.7

1.5

nmol/l

2.1

3.6

0.58

122

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.88

7.41

1.0

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

116

2.76

7.33

1.3

1.2

79.2

87.7

0.62

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

481

3209

1.31

7.05

1.8

1.7

—

(3018133) Calcium [Moles/volume] in Urine

149

2.50

7.03

3.5

3.0

mmol/l

2.5

2.7

0.26

136

(3030313) Adrenal Ab [Titer] in Serum

5.49

7.01

1.2

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

528

3570

1.29

7.00

1.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1357

0.56

6.88

1.3

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1224

9076

1.19

6.82

1.5

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

198

1145

1.50

6.75

1.5

1.8

mu/l

310.8

258.9

1.96

190

1069

(3033086) Enterovirus NOS Ab [Titer] in Serum

11.51

6.73

1.0

1.1

—

(3042517) Benzodiazepines panel - Urine

17.27

6.57

2.6

2.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.85

6.55

1.5

1.3

ng/l

125.1

96.9

0.36

(3029075) Extractable nuclear Ab panel - Serum

134

2.52

6.51

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

104

2.74

6.51

1.4

pmol/l

19.9

14.7

0.65

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

114

2.65

6.49

1.4

1.2

66.5

90.4

2.27

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

149

817

1.58

6.47

1.5

1.3

pmol/l

50.3

78.6

2.30

202

(3014051) Protein [Presence] in Urine by Test strip

218

1298

1.46

6.45

2.1

2.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

202

1185

1.48

6.44

1.2

1.1

u/ml

2.2

1.7

0.17

542

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

146

2.43

6.37

1.1

u/ml

22.9

14.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.56

6.31

4.2

5.9

—

(44806071)

3.82

6.29

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

11.87

6.29

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

268

2.00

6.06

2.0

1.8

—

(3043409) Potassium [Moles/volume] in Arterial blood

990

0.53

5.91

4.7

3.1

mmol/l

4.1

3.8

2.64

934

(3034274) Bile acid [Moles/volume] in Serum --fasting

319

1.90

5.89

2.1

3.5

umol/l

8.2

18.1

2.00

244

(40762887) Creatinine [Moles/volume] in Blood

15.54

5.76

1.4

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

163

938

1.51

5.76

1.5

1.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

416

1.77

5.72

1.2

—

(3019150) Specific gravity of Urine by Refractometry

1166

11518

0.86

5.67

3.3

kg/l

1.0

0.65

260

1678

(3003888) Timothy IgE Ab [Units/volume] in Serum

183

1082

1.47

5.67

1.1

u/ml

3.3

3.9

0.30

610

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

127

694

1.59

5.66

2.1

2.3

u/l

1666.5

3948.5

0.62

253

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

4.48

5.65

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

213

1299

1.42

5.60

4.0

2.6

mg/l

25.2

28.5

0.56

780

(3045683) HLA typing for celiac disease panel - Blood or Tissue

295

1.91

5.56

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.24

5.52

1.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

507

1.67

5.44

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

324

1.84

5.34

1.4

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

4.49

5.27

1.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

326

1.83

5.25

1.4

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

133

749

1.54

5.23

1.1

—

(3020891) Body temperature

102

1392

0.63

5.18

4.6

3.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

431

1.71

5.10

2.5

2.3

14.0

13.6

0.11

195

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

135

2.30

5.06

1.0

1.4

nmol/l

128.3

127.6

0.01

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

395

1.73

4.99

2.7

2.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.64

4.99

1.3

1.1

umol/24h

266.8

394.2

1.38

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.81

4.98

1.2

1.6

—

(3009015) Lactate [Moles/volume] in Synovial fluid

3.02

4.97

1.5

1.3

mmol/l

6.1

7.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

175

1058

1.43

4.88

1.1

u/ml

0.7

0.9

0.29

529

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.76

4.88

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

396

2710

1.27

4.87

1.5

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

322

0.27

4.81

1.3

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

155

2.17

4.81

1.5

ug/l

12.4

8.7

2.55

155

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.70

4.79

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.70

4.79

1.2

1.1

—

(3025577) Chromium [Mass/volume] in Blood

394

1.71

4.78

2.0

ug/l

2.4

0.01

335

(40767503) Oxygen content in Capillary blood by calculation

128

731

1.52

4.76

2.9

2.1

17.1

16.8

0.29

100

397

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.75

4.74

3.4

2.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.84

4.69

3.8

3.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

443

1.66

4.65

2.1

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

271

1.85

4.61

1.2

1.1

ng/l

1462.8

312.5

0.56

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

723

0.52

4.54

1.3

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

204

1285

1.38

4.53

2.9

3.5

u/ml

168.5

238.8

0.45

191

1174

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.50

4.45

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

366

2511

1.27

4.45

1.3

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

183

1136

1.40

4.44

1.6

e6/l

37.8

13.4

0.90

137

838

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

183

1137

1.40

4.42

1.7

e6/l

3976.0

1229.2

0.37

149

888

(3026470) Cobalt [Mass/volume] in Blood

410

1.67

4.41

2.1

2.0

ug/l

4.3

3.4

0.47

365

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

161

2.09

4.40

2.7

3.2

umol/l

27.9

27.8

0.01

131

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

379

1.69

4.35

1.0

ng/l

803.4

675.8

1.69

264

(3019977) pH of Arterial blood

163

2.07

4.28

2.0

2.1

7.4

0.34

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

381

1.68

4.27

1.0

ng/l

50.0

44.1

0.58

276

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.32

4.26

10.1

7.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.98

4.23

1.3

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

147

2.12

4.19

1.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

200

1.94

4.19

1.2

u/ml

6.6

17.9

0.41

146

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

101

565

1.55

4.18

1.3

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.71

4.14

1.3

1.5

nmol/l

15.0

19.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

380

1.66

4.06

1.0

ng/l

342.6

367.4

0.27

281

(4038314)

4.13

4.05

1.1

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

127

2.18

4.01

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

132

789

1.45

3.99

1.1

u/ml

6.4

5.2

0.21

324

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

274

1.77

3.90

1.5

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

178

0.24

3.85

1.0

1.4

—

(40765096) Chromosome analysis panel by Banding

201

1.89

3.81

1.3

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

158

990

1.38

3.70

1.1

au/ml

24.8

11.0

—

(3009871) Measles virus Ab [Titer] in Serum

191

1.90

3.70

1.5

1.7

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.57

3.68

6.8

5.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

313

0.36

3.67

1.1

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

229

1.81

3.65

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

6.90

3.65

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

386

1.61

3.62

2.1

1.8

u/field

3.2

2.5

0.22

163

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

243

1.78

3.59

1.0

mmol/l

19.1

19.8

0.55

236

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

231

1.80

3.56

1.0

kpa

7.7

7.2

1.08

200

(3004959) Base excess in Arterial cord blood by calculation

231

1.80

3.56

1.0

mmol/l

-0.0

-1.6

—

(3006598) pH of Arterial cord blood

231

1.80

3.56

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.68

3.52

1.1

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.45

3.51

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.45

3.51

6.8

5.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.65

3.48

1.4

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.92

3.46

1.0

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.92

3.46

1.1

1.4

—

(3008898) HLA-B27 [Presence]

251

1703

1.28

3.43

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.72

3.41

1.0

1.1

u/ml

1.9

0.5

0.61

(3021706) Oxygen [Partial pressure] in Arterial cord blood

228

1.78

3.41

1.0

kpa

3.0

3.3

0.92

198

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

301

0.37

3.40

1.9

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

108

2.16

3.37

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

311

0.39

3.35

1.1

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

323

0.40

3.34

1.1

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

262

1.72

3.33

1.2

1.4

mmol/l

12.2

8.9

1.13

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

186

1.86

3.33

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

174

1.89

3.31

1.1

1.0

—

(40758358) Immune stain study

3.24

3.21

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

106

2.12

3.11

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

106

2.12

3.11

1.4

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

106

2.12

3.11

1.4

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.58

3.11

1.0

1.1

u/ml

0.2

1.2

—

(3049242) von Willebrand panel - Platelet poor plasma

5.31

3.10

1.9

1.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

154

1.91

3.08

1.4

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

135

854

1.37

3.05

3.4

2.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

453

1.51

3.03

1.1

iu/ml

9.1

10.9

0.18

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

552

1.46

3.01

1.4

1.3

nmol/l

0.2

0.3

2.21

393

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.45

2.94

1.4

2.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.88

2.90

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

280

1.64

2.89

1.1

u/l

1.8

1.1

0.44

153

(40768800) Prostate Pathology biopsy report

209

2270

0.79

2.87

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.18

2.86

1.3

1.5

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.39

2.85

3.1

2.8

16.7

4.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

5.49

2.83

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

6.47

2.74

1.2

1.3

mmol/24h

2.4

2.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

6.47

2.74

1.3

1.0

titre

2190.0

2428.8

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.41

2.74

1.1

u/ml

0.1

2.5

0.87

(42870560) Thyrotropin [Units/volume] in Cord blood

298

1.60

2.74

1.0

mu/l

11.0

8.5

1.17

269

(40758292) HTLV I+II Ab panel - Serum

119

1.96

2.68

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

113

712

1.37

2.67

1.1

u/ml

0.6

0.2

0.71

197

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

407

0.53

2.66

1.2

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

154

1018

1.31

2.65

1.1

u/ml

0.9

3.2

3.87

268

(3050129) First trimester maternal screen panel - Serum or Plasma

440

0.55

2.65

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

417

0.54

2.64

1.4

1.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

3.20

2.64

2.4

1.2

—

229.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

129

834

1.34

2.60

1.1

u/ml

3.8

4.9

0.37

348

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

139

1.86

2.59

1.3

1.4

u/ml

15.8

14.3

0.04

110

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.33

2.57

1.1

u/ml

0.1

0.9

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

104

1.99

2.51

3.8

6.9

u/l

40.3

91.4

0.84

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.08

2.50

1.3

1.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.61

2.47

1.2

1.3

1.6

1.3

1.20

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

219

1.66

2.46

1.3

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

372

0.53

2.43

1.1

1.4

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

3.84

2.42

1.3

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

5.18

2.40

1.0

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

542

0.62

2.35

2.0

1.5

26.9

35.7

0.77

326

(3006442) Creatine [Moles/volume] in Serum or Plasma

368

0.54

2.35

1.9

1.3

umol/l

54.2

73.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

140

1552

0.77

2.34

2.1

1.9

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

474

1.42

2.32

1.3

2.0

mg/l

6.3

3.3

2.97

458

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

6.16

2.29

4.2

5.0

umol/l

450.0

436.9

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

374

0.55

2.26

1.1

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

374

0.55

2.26

1.1

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

372

0.56

2.22

1.1

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

343

2530

1.18

2.20

1.1

titre

220.6

305.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

169

1164

1.26

2.18

1.3

miu/ml

155.4

212.8

1.16

586

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

142

1.76

2.15

1.8

1.6

—

115.6

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.78

2.14

3.4

11.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

117

1.85

2.14

1.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

254

1831

1.20

2.13

1.4

iu/l

25.0

34.8

5.04

206

1545

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

5.39

2.12

1.2

1.0

u/l

594.4

593.9

—

(3016135) IgD [Mass/volume] in Serum

4.31

2.11

1.2

1.1

mg/l

258.1

32.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.29

2.11

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

542

1.37

2.10

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

179

0.43

2.08

1.0

2.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

2.16

2.07

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.57

2.04

1.6

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.57

2.04

1.1

1.2

umol/24h

2.3

1.5

0.69

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.19

2.03

1.7

1.2

pmol/l

75.9

39.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

716

0.70

2.02

1.2

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

108

1209

0.77

2.00

2.0

1.9

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

120

1.80

1.99

1.1

1.6

mmol/l

10.3

7.8

2.42

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.98

1.99

1.5

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

133

1.75

1.98

1.2

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

136

925

1.27

1.98

1.3

1.2

—

(3017509) Phencyclidine [Presence] in Urine

3.00

1.92

1.9

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

223

2291

0.84

1.90

1.7

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

129

1.74

1.88

1.2

1.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

123

1.75

1.86

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.88

1.84

18.8

8.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

609

1.32

1.82

1.6

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

260

1.50

1.79

1.4

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.92

1.76

1.9

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

106

1.79

1.76

1.4

1.3

75.4

61.4

1.30

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

192

1.57

1.76

1.1

1.2

ratio

1.1

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.06

1.76

4.3

2.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

186

1.58

1.73

1.9

1.8

mg/l

10.0

10.3

0.15

153

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.24

1.66

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

3.24

1.66

1.0

1.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

127

0.41

1.65

7.3

5.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

128

0.40

1.65

3.7

2.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

182

1.57

1.64

1.3

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

162

1.60

1.62

1.5

2.2

u/l

28.9

33.7

0.14

148

(3015183) Erythrocyte sedimentation rate

305

0.59

1.61

1.3

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.16

1.59

1.3

2.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1688

15313

0.94

1.52

3.8

2.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.74

1.50

2.0

3.4

—

(3000285) Sodium [Moles/volume] in Blood

2.07

1.45

1.1

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

274

1.42

1.43

1.7

1.8

u/field

3.1

3.4

0.05

194

(3001686) Cold agglutinin [Titer] in Serum or Plasma

101

1.71

1.41

1.7

1.5

titre

184.3

166.4

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.08

1.39

1.2

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.08

1.39

1.0

u/ml

0.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.71

1.35

3.4

3.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.59

1.33

1.0

1.4

nmol/l

171.5

361.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.59

1.33

1.0

—

(4212803)

1.99

1.33

1.2

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

151

1.54

1.31

1.3

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

186

1.49

1.31

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.88

1.30

1.0

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.88

1.30

1.0

u/ml

0.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.88

1.30

1.8

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

150

0.52

1.30

1.1

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

3362

28170

1.04

1.28

3.4

3.0

estimate

0.0

0.00

191

4877

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

502

1.27

1.21

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

3421

28705

1.04

1.21

3.6

3.0

estimate

0.0

0.00

259

5107

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.35

1.19

1.2

1.0

u/l

9.0

28.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.35

1.19

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

114

1.59

1.17

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

114

1.59

1.17

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

114

1.59

1.17

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

114

1.59

1.17

1.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.75

1.17

1.1

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.09

1.16

1.3

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

128

1.55

1.16

1.4

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

139

1016

1.18

1.14

1.2

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

224

0.62

1.13

1.9

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

139

1018

1.18

1.12

1.2

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

223

0.62

1.11

1.9

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.97

1.09

1.0

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

160

1.46

1.05

1.6

u/ml

10.5

7.1

—

(3003694) ABO and Rh group [Type] in Blood

2045

17049

1.04

0.97

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

214

1.37

0.97

3.1

3.6

—

(4281824)

669

1.20

0.95

1.3

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

655

5299

1.07

0.94

3.6

2.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

321

3034

0.91

0.93

1.8

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.84

0.92

1.0

1.1

—

(3044889) 12 lead EKG panel

5003

42484

1.03

0.85

4.4

2.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

337

0.74

0.84

1.6

2.9

42.1

36.5

—

(4027681)

282

1.29

0.82

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.73

0.81

1.1

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

373

0.76

0.80

5.0

7.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.85

0.80

1.2

1.8

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.68

0.79

1.0

1.1

—

23.1

—

(3035933) Granulocytes/100 leukocytes in Blood

238

1.31

0.79

1.3

1.4

—

(3013762) Body weight Measured

0.00

0.77

0.0

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.77

0.0

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.78

0.77

1.0

1.1

—

29.4

—

(3047181) Lactate [Moles/volume] in Blood

692

0.83

0.76

5.7

2.6

mmol/l

1.6

1.3

1.41

588

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

256

1.28

0.74

1.3

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.65

0.74

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2725

22965

1.03

0.74

3.6

4.0

21.9

21.0

1.90

1230

11423

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.05

0.74

1.2

1.0

36.7

35.7

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.05

0.74

1.2

1.0

7.0

9.0

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.05

0.74

1.2

1.0

20.1

22.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

234

1.29

0.72

1.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.96

0.71

1.0

1.1

—

(3000012) Reticulocyte production index

256

0.74

0.68

1.7

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.49

0.65

1.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.49

0.65

1.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

214

1688

1.10

0.64

5.8

4.6

mmol/l

24.9

24.6

0.36

205

1553

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.61

0.61

1.1

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.66

0.60

1.4

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

251

1.24

0.57

1.1

1.0

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.67

0.56

1.5

1.3

mg/l

1.2

1.9

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

575

0.85

0.54

1.8

1.4

g/l

0.9

1.0

0.39

575

(40763590) HLA-DQ beta [Type]

1.57

0.54

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.57

0.54

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

333

2700

1.07

0.53

3.4

4.2

u/ml

36.2

50.7

1.64

317

2621

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.39

0.52

1.3

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

123

1.33

0.52

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.51

0.51

1.1

—

(3025130) Human papilloma virus identified in Specimen

615

0.87

0.49

1.5

1.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.65

0.49

1.7

2.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.46

0.48

1.0

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

3346

28441

1.02

0.48

5.7

4.0

estimate

0.0

0.00

291

5028

(4133840)

202

0.77

0.47

1.6

1.2

—

(40768795) Lymph node Pathology biopsy report

701

1.12

0.47

1.2

1.3

—

(3004451) EKG impression Narrative

1.36

0.47

1.3

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.40

0.45

1.3

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.46

0.45

1.5

2.3

—

(3016750) Collection duration of Urine

1.36

0.44

2.5

2.1

min

466.1

481.8

0.36

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

478

0.87

0.42

1.2

1.1

—

(3001729) Color of Synovial fluid

1.41

0.42

1.3

1.7

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.41

0.0

1.2

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.41

0.0

1.2

—

2309.5

—

(44813793)

367

1.15

0.40

1.2

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

442

1.13

0.38

1.2

u/ml

5.6

2.7

0.40

169

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

209

1.20

0.37

1.1

miu/ml

1198.1

1434.9

0.66

209

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

499

0.88

0.37

3.8

5.7

u/ml

41.6

128.2

2.12

172

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.44

0.35

5.0

4.0

—

0.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.33

0.34

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.69

0.33

1.7

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

310

0.86

0.31

1.8

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.25

0.27

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.23

0.27

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

597

1.08

0.26

4.1

3.8

u/ml

26.4

48.4

1.97

589

(1617658) Protocol used for examination of sentinel lymph nodes

529

0.91

0.25

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

257

0.87

0.24

4.8

3.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

612

5406

0.97

0.24

1.5

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1498

13103

0.98

0.23

3.0

—

(40760410) HLA-B [Type] by High resolution

1.31

0.23

1.0

—

(40760409) HLA-A [Type] by High resolution

1.31

0.23

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.75

0.22

1.1

—

(3013862) HLA-DP [Type]

1.23

0.22

1.0

—

(40761535) Cells panel - Urine sediment

492

4351

0.97

0.22

3.4

3.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.6

—

414.8

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

1.4

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

523

0.92

0.21

1.5

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

3.7

—

1.7

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.20

0.20

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.18

0.19

1.0

1.4

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

134

1.16

0.19

1.2

2.9

ng/l

77.6

153.4

—

(3052592) Norovirus Ag [Presence] in Stool

1.16

0.17

1.3

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.12

0.17

1.6

2.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

104

0.83

0.17

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

235

1.10

0.16

1.2

1.7

ug/l

6.4

9.0

0.31

164

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

257

0.91

0.16

1.6

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.10

0.15

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.78

0.15

1.3

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.78

0.15

2.8

4.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

436

1.07

0.15

1.3

1.2

u/ml

30.2

5.7

0.51

157

(3015076) Soybean IgE Ab [Units/volume] in Serum

390

0.93

0.15

1.2

1.1

u/ml

0.3

1.9

0.80

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.80

0.14

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

130

1.13

0.13

1.1

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.17

0.11

1.1

2.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

260

0.93

0.11

3.2

2.9

umol/l

54.1

123.2

2.58

(21494814) CD8 cells/100 lymphocytes in Specimen

232

0.93

0.09

1.7

2.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.05

0.09

2.4

3.1

—

(40768793) Breast Pathology biopsy report

161

1357

1.02

0.09

1.4

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.10

0.09

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.78

0.08

1.4

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.04

0.08

2.9

2.0

u/field

0.6

0.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

101

1.11

0.08

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

143

1.09

0.07

1.2

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.83

0.07

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.86

0.07

1.7

1.1

—

(3012501) Base excess in Blood by calculation

740

0.98

0.05

8.8

2.7

mmol/l

3.1

2.4

1.62

492

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

137

0.94

0.03

2.7

2.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

311

1.03

0.02

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

249

0.97

0.02

2.1

2.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

257

0.97

0.01

1.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

202

1.02

0.00

4.1

3.4

mg/l

6.0

8.0

1.08

162

(3010421) pH of Blood

101

866

1.01

0.00

8.2

2.8

7.4

2.03

721

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

164

1.00

0.00

1.0

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.4

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

12.9

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.2

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.98

0.00

2.4

3.0

mg/l

15.6

21.4

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

2.4

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.98

0.00

3.6

2.1

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.0

1.2

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

0.0

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.3

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.6

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.0

1.3

—

36.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

143.4

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CPAP and mortality.

Females

Parameter	HR [95% CI]	p-value
CPAP	3.242 [2.82, 3.73]	< 0.001
Birth year	0.997 [0.99, 1.0]	0.398

During the follow-up period (1.1.1998 — 31.12.2019), 3807 out of 20443 females with CPAP died.

Males

Parameter	HR [95% CI]	p-value
CPAP	2.609 [2.26, 3.01]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 5627 out of 33117 males with CPAP died.

Mortality risk

Mortality risk for people of age

years, who have CPAP.

N-year risk	Females	Males
1	0.307%	0.48%
5	2.055%	2.949%
10	4.78%	7.29%
15	9.292%	13.455%
20	15.925%	22.439%

Relationships between endpoints

↥

Index endpoint: CPAP – Continuous positive airway pressure

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Continuous positive airway pressure

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints